Podcasts about Brilliant

It's time for another BIG and BRILLIANT adventure into the world of science on this week’s Science Quest! In Science in the News, NASA is preparing to launch the Artemis 2 mission, sending astronauts around the Moon for the first time in 50 years. UK beekeepers report worrying losses this winter, and Elena Hoicka from the University of Bristol joins Dan to explore the surprising news that babies may begin learning to lie from a very young age! It’s time for your questions too. Clem wants to know how weather forecasts work, and Cait Newport from Oxford University answers Apolline’s question about whether or not Goldfish really do have a three-second memory. Dangerous Dan introduces the Oak Processionary Caterpillar, a creature you definitely do not want to get too close to. And in Battle of the Sciences, Dr Christopher Terrell-Nield takes us deep into the fascinating world of cave biology and the life that thrives in total darkness. Plus, Kareena and K-Mistry head to the British Museum to discover the chemistry behind prehistoric cave art. What we learn about: • Whether goldfish really have a three-second memory• How weather forecasts are made• NASA’s Artemis 2 mission to the Moon• Why bees are disappearing in the UK• Whether babies can learn to lie• The oak processionary caterpillar• How animals survive in caves• The chemistry behind prehistoric cave art All that and more on this week’s Science Quest!Join Fun Kids Podcasts+: https://funkidslive.com/plusSee omnystudio.com/listener for privacy information.

Most CEOs believe their biggest challenge is strategy. It's not. In this episode, Lisa Goldenthal breaks down the real leadership trap burning out high-performing CEOs—not lack of vision, but the hidden cost of becoming the decision bottleneck. Through sharp insights and practical frameworks, Lisa challenges leaders to confront a critical question: If you stepped away for 30 days, would your company accelerate—or stall? This conversation dives into what truly slows execution inside organizations—over-centralized decisions, lack of ownership, and leaders operating in the weeds instead of at altitude. Lisa unpacks why many CEOs unintentionally become the ceiling of their company—and how to shift from carrying the business to building systems that scale. You'll learn: ·        Why execution slows when too many decisions flow back to the CEO ·        How to identify if you're leading strategically or reacting operationally ·        The difference between building a high-performing system vs. over-functioning as a leader ·        How energy, mindset, and clarity directly impact decision quality ·        What it takes to lead at altitude in fast-moving, high-pressure environments This episode is a must-listen for CEOs, founders, and executive leaders ready to eliminate decision bottlenecks, reclaim leadership capacity, and scale without burnout. Because in today's environment, success doesn't come from doing more. It comes from deciding better—and building organizations that don't depend on you for every move.  

On this episode of From Ballparks to Buzzer Beaters, Perry and Swin discuss this year's March Madness bracket.

Bestselling author Patrick Gale joins Philippa on the Quick Book Reviews Podcast to discuss his powerful new novel Love Lane, plus brilliant escapist book recommendations including The Selection and An Offer from a Gentleman.In this episode of Quick Book Reviews, Philippa talks to bestselling author Patrick Gale about his moving and deeply personal new novel Love Lane.Patrick returns to the podcast to discuss the inspiration behind the book, how family history shaped the story, and why this emotional historical novel might be his most personal work yet. The conversation also dives into writing routines, fountain pens, notebooks, and the joy (and therapy!) of storytelling.If you enjoy powerful character-driven fiction, family sagas, and historical novels filled with heart, this is an episode you won't want to miss.Pre-order Love LanePatrick Gale's beautiful new novel Love Lane publishes soon — and pre-orders really help authors and bookshops.Pre-order your copy here:

The world tells you to shrink but you are too phenomenal for that! Let's make sure you know it

Join the H-Hour Patron Community at patreon.com/hkpodcasts ***** In this H-Hour episode, I chat with actor and ex-Queen's Royal Hussars Officer Alex Brockdorff about breaking into film/TV via commercial crew work—starting as a runner and becoming a location manager to “keep a roof over my head” while pursuing acting—and why set life suits ex-military planning, teamwork, and initiative. Brockdorff praises the technical craft of production, contrasts commercials with long-form drama, and describes his unconventional audition for Warfare, the film's memory-based scripting, long takes, tight hours, and why it felt special, calling it “fucking grim” with “no sweeping strings” or “American Eagle” heroics. He recounts leaving the Army, bottoming out in 2015, seeking help through Combat Stress and HorseBack UK, and urges veterans to ask for help. ---- Alex Brockdorff Is an actor and former soldier. He joined the Army in 2008 with deployments to both Iraq and Afghanistan - in 2014 he left the military to pursue a career in film. He as appeared in a slate of films, network and streaming television dramas, and most recently he played Mikey in the critically acclaimed WARFARE (A24). https://www.alexbrockdorff.com/

It's still time for another BIG and BRILLIANT adventure into the world of science on this week’s Science Quest! In Science in the News, a giant iceberg drifting around Arctic waters is down to its final weeks before it breaks apart completely, scientists have built a mouse-sized robot to inspect parts of the Large Hadron Collider, and Ewan Bodenham joins us to explain why he named a brand-new ancient crocodile species after his old physics teacher. Dangerous Dan is back with the scorpion mouse, a tiny but fierce creature with some seriously surprising powers. And in Battle of the Sciences, we’re digging into planetary mineralogy with Susanne Schwenzer, exploring the rocks and minerals that help scientists understand how planets are formed. Plus, in Geology Rocks, Finley travels across the world and back through time to discover how rocks, fossils and volcanoes helped shape our planet. What we learn about: • Why rainbows are curved• Why one giant Arctic iceberg is about to disappear• How a tiny robot could help scientists inspect the Hadron Collider• Why a new ancient crocodile was named after a teacher• The fierce scorpion mouse• How rocks and minerals reveal the history of planets All that and more on this week’s Science Quest!Join Fun Kids Podcasts+: https://funkidslive.com/plusSee omnystudio.com/listener for privacy information.

In this episode I explore a newly discovered social network where AI agents interact — revealing confabulation, identity swaps, and surprising debates — and discuss what that means for therapists and private practice: the risks, ethical questions, and practical time-saving possibilities. I also react to Zoom's new AI avatars, share a reflective trip to Phillip Island, and invite listeners who are ready for private-practice coaching to apply.

Jeannette breaks down the decision making blueprint essential for shifting a business from chaos to clarity, arguing that a CEO's primary job isn't "doing" or "firefighting," but making quality decisions under uncertainty.  By separating emotion from evidence and empowering teams through strategic delegation, leaders can overcome decision fatigue and move their organisations toward a positive upward spiral of growth and confidence. You'll Learn Why: A world-class CEO's primary responsibility is making decisions under uncertainty rather than managing day-to-day operations. Separating your emotions from factual evidence is the most effective way to gain clarity during a business crisis. True leadership involves shifting from working in the business to working on the business by creating principles rather than rigid policies. Indecision is often more expensive than making a 70% certain move and adjusting course later. This episode is living proof that no matter where you're starting from — or what life throws at you — it's never too late to be brave, bold, and unlock your inner brilliant. Visit ⁠https://brave-bold-brilliant.com/⁠ for free tools, guides and resources to help you take action now

Steve Forbes celebrates the 250th anniversary of Adam Smith's “The Wealth of Nations” and encourages today's leaders to heed its timeless principles of prosperity, low taxes, free trade, stable money anchored by gold.

Dan Counce. 3 time SLU National Champ, Hermann Award Winner, 10 Years a pro, more years in the MLS front office in Denver, AND... a Northsider. Brilliant chat with the STL Soccer Hall of Famer about his path, career, leadership in Denver, and more! #mls #rapids #soccer #stlouis #hermanntrophy #ncaasoccer #slusoccer Learn more about your ad choices. Visit megaphone.fm/adchoices

We've finally seen a star exploding in real time. For the first time, we have a front-row seat to one of the most violent events in the universe: a supernova. But there's a catch - the shape of the explosion was not what we expected. In this video, we investigate the inner workings of the blast to find out what's really going on inside.▀▀▀▀▀▀Astrum's newsletter has launched! Want to know what's happening in space? Sign up here: ⁠https://astrumspace.kit.com⁠A huge thanks to our Patreons who help make these videos possible. Sign-up here: ⁠https://bit.ly/4aiJZNF▀▀▀▀▀▀If you love learning about science as much as I do, head to http://brilliant.org/astrum to learn for free for a full 30 days. You'll also receive 20% off a premium annual subscription, giving you unlimited access to everything on Brilliant.

Who is Mitchell?Mitchell Levy is a passionate advocate for purpose-driven business relationships. Through his work, Mitchell observed a common frustration among professionals on platforms like LinkedIn: many reach out without a clear purpose or differentiation, often leading with sales pitches rather than genuine value. Recognizing this disconnect, he champions the power of having a “North Star”—a clear vision and understanding of the problem you solve and the unique value you bring. Mitchell encourages business owners, regardless of their size, to approach networking with intention and a customer-centric mindset. His insights help professionals articulate their purpose and foster meaningful, effective connections in the digital age.Key Takeaways* Mitchell Levy reveals the power of clarity: leaders and business owners need a simple North Star—a CPOP—in under 10 words. When you know where you're headed, decisions get easier and credibility follows.* Tired of random LinkedIn messages? Mitchell shares why real connection starts when you understand who you truly serve and their real pain or joy. Purposeful outreach beats cookie-cutter pitches every time.* Small business? Big CEO? Mitchell's “executive abundance” works for all. Growth happens when you get clear on your purpose, your people, and the possibilities you can create. Alignment is everything.* Elevator pitches are overrated. What matters is knowing, in a few words, who you're helping and why. That's your true vibration—one you won't need to memorize, just live.* Want credibility? Keep learning, stay coachable, and be willing to reset your focus. Mitchell's path: clarity, purpose, connection. Change your story, and your impact grows—no matter your size.Don't forget: If you want to connect, ask questions, or get notified about upcoming guests like Mitchell, subscribe to the Systemise.Me newsletter here. You only need your first name and email—easy as (coffee) pie!Thanks for sharing a cup with us this week. Here's to strong coffee, smart hiring, and believing in the dreams you're just starting to imagine.And don't forget: keep an eye out for next guest. To submit your own questions, subscribe to our newsletter and join the conversation!P.S. Loved this episode? Hit reply and let us know what resonated most_________________________________________________________________________________________________Subscribe to our newsletter and get details of when we are doing these interviews live at www.systemise.me/subscribeFind out more about being a guest at : link.thecompleteapproach.co.uk/beaguestSubscribe to the podcast at https://link.thecompleteapproach.co.uk/podcastHelp us get this podcast in front of as many people as possible. Leave a nice five-star review at apple podcasts : https://link.thecompleteapproach.co.uk/apple-podcasts and on YouTube : https://link.thecompleteapproach.co.uk/Itsnotrocketscienceatyt!Do You Need a P.A.T.H. to Scale?We help established business owners with small but growing teams:go from feeling stuck, sceptical, and tired of wasting time and money on false promises,to running a confident, purpose-driven business where their team delivers results, customers are happy, and they can finally enjoy more time with their family -with a results-based refund guarantee: if you follow the process and it doesn't work, we refund what you paid.This is THE P.A.T.H. to scale your business.————————————————————————————————————————————-TranscriptNote, this was transcribed using a transcription software and may not reflect the exact words used in the podcast)SUMMARY KEYWORDSexecutive coaching, credibility, LinkedIn sales tactics, business owners, CEOs, executive abundance, fast-growing companies, Inc 5000, Marshall Goldsmith 100 coaches, clarity, North Star, customer point of possibilities, CPOP, marketing cookie cutter, business scaling, founders, path to scale, leadership, business strategy, elevator pitch, business clarity, operating system of credibility, business growth, credibility expert, solopreneurs, company purpose, personal compass, decision-making, business differentiation, referral partners, customer focusSPEAKERMitchell Levy, Stuart WebbStuart Webb [00:00:31]:Hi and welcome back to five Questions over Coffee. Here is my coffee. Now be careful spill that, it's quite full at the moment. Mitchell. Yeah, well done. It's a Guinness, so well done. Mitchell Levy here is a leading executive coach, a global credibility expert and I'm looking forward to him walking through his process today talking to us a little bit about how he helps get leaders real credibility. So Mitchell, thank you for making a few minutes available to come and speak to us here on It's Not Rocket Science.Stuart Webb [00:01:06]:Five Questions over Coffee.Mitchell Levy [00:01:08]:My pleasure. Thanks for having me Stuart. Really nice to, really nice to engage with you.Stuart Webb [00:01:14]:Well that's terrific. So let's start by trying to understand the sort of person you're reaching out to with helping them with their credibility.Mitchell Levy [00:01:25]:You know it's interesting, I, I have two distinct audiences. So as an executive coach, so I'm part of The Marshall Goldsmith 100 coaches, some of the top executive coaches on the planet. And for that audience it is fast growing CEOs leading the future with executive abundance. Now in if you were in the U.S. i say Inc 5000, which basically is the, the top five, 5,000 fastest growing companies in the U.S. but yeah, since this is Australian, I'll just say fast growing company. So that is one group of one audience. And, and executive abundance is a new framework I'm introducing into the marketplace.Mitchell Levy [00:02:12]:It's been my executive coaching for years. But one of the things you, you asked me in the green room, how you doing? Last week I advanced to candidacy on my PhD program and so I am actually doing a dissertation and then we'll, we'll write a book, do coursework and chatbots on executive abundance.Stuart Webb [00:02:33]:On your Congratulations. Thank you doctor. Not a, not a, not an easy thing to do as I recall. So tell me a little more about sort of the people that you're helping that you've just sort of described. Give us an example of sort of things that they might have tried before and the ways in which you help them.Mitchell Levy [00:02:54]:Well so by the way, let me do the second audience and then you could tell me which one you want me to.Stuart Webb [00:02:59]:Oh, no problem.Mitchell Levy [00:03:00]:So the second audience is business owners escaping slimy LinkedIn sales tactics. Perfect. Perfect. That's exactly what I want to get right. It's, I've been on LinkedIn since before they were making money. Now a couple hundred thousand people could say that, but there's one thing I could say that nobody else in the planet can say and that is I was in the room with two, with two of the five founders And I was commissioned to have written and published the first book on LinkedIn. I've looked at a couple hundred thousand LinkedIn profiles and I have a system and approach that helps people drive one to one business relationships with people on LinkedIn. And I can do it at scale.Mitchell Levy [00:03:43]:And so it's the 5% on LinkedIn functionality that brings 80% of value. So that sort of answers that question for the business owner side. On the executive coaching side, the question is what sort of things, what have they tried before? You know, I think I'm going to generically say something and then you could, you could drill me in if we need to. Life is, and business is really, really simple.Stuart Webb [00:04:14]:It's not easy, right?Mitchell Levy [00:04:17]:And what's not easy about it is the fact that even if you know the answer in your heart, in your head, in your body, you know exactly what to do. There's chaos out there and there's these experts who have what I call marketing cookie cutter approaches. And so in, in your vernacular, there's a wicked problem they have and they're trying to solve it. They're going to go out and talk to a ton of people and they get such a diverse range of answers and then they hit one they like, but they don't hold on to it. And so for those that I work with on executive coaching, the first thing we need to do is establish the clarity, establish the playground they play and establish what I call their cpop, their customer point of possibilities. And that is in less than 10 words, where they're executing on their purpose. That's for the company or for the individual. And once you have that, then you can deploy an operating system of credibility.Mitchell Levy [00:05:23]:But until you have that, it's really hard to make decisions because you need a compass, you need a personal compassion that you can actually live by. You need your own North Star. And, and so that's, in terms of business, we need a North Star and that's, that's where we start. And after that, when I hang out with somebody who's doing executive coaching, I'm just, I'm just helping them understand how they're making decisions in their North Star, how they propagate it throughout the organization. It's, it's always fun to see and everyone's different. Some are really fast, some take a little bit more time, some need to fall down a couple of times so they can get up. But generally speaking, what I do is extremely simple, but apparently it's not so easy.Mitchell Levy [00:06:18]:Let me just try and link those two customer types together. In some way, I think something like LinkedIn requires somebody to have what you've just described in terms of the Northstar, what they're doing and be very clear about what their problem solution is. I see an awful lot of people on LinkedIn just sort of, you know, reaching out quite randomly to people, sending the immediate, why don't we just. Why don't we just cut to the chase? Buy my. Buy my stuff, buy my thing. And I find myself very frustrated by the fact they don't actually have, as you've just described it, a real purpose, a real point of differentiation, a real customer focus behind that message, because they're not able to actually articulate what it is they're actually going to do. So there's a great deal of sort of overlap between those two things that you've described, because business owners, even if they're small, need to have that North Star about what it is they're reaching out to do with LinkedIn and why they need to do it. Am I wrong?Mitchell Levy [00:07:24]:No, no, no. It's, it's a great observation. Thank you for seeing it. It shows a little bit about who you are. It turns out that if I'm working with a CEO with a couple hundred, couple thousand, tens of thousands employees, there's a lot more what to say, politics and vested interest and vested groups in place. When I'm working with a CEO who's a solopreneur, where they've got five or 10 people in their organization, it's a whole lot easier to make change. And so it's a different price point, a lot less expensive for the LinkedIn work. And it turns out that the lessons I learned in both places apply to each other.Mitchell Levy [00:08:14]:I call the LinkedIn guys mini executive abundance, even though I don't necessarily call it to them. In my mind, I, I'm deploying executive abundance at the individual level as well, which is a great way to. So it's, it's technically the same thing, but most of the time I don't, I don't say it that way.Stuart Webb [00:08:33]:Yeah. And thank you for. Thank you for sort of endorsing the fact that I had misunderstood it, because I do think that this idea of executive abundance applies to some smaller businesses. They just don't know it applies. They just don't recognize it in themselves. And I think a lot of business owners probably don't grow because they don't know how to do that. They don't know how to start to let themselves have that abundance. So talk to me a bit, a little bit Mitchell about.Mitchell Levy [00:09:01]:Well, I know you've got a valuable offer that you're going to put. And we've got this, we're going to have this in our vault, which I'm going to show now on screen, which is a www.systemize sys t e m I s e me free stuff. So you'll be able to get hold of some of the stuff that Mitchell is going to talk about there. So Mitchell, talk to me a little bit about the process that you go through. So if people were thinking I need to get and understand this guy a bit more, talk about the process. Talk about how you help them with this abundance as you're talking about.Mitchell Levy [00:09:38]:So we'll practice on you. Stuart, you've demonstrated that I should do that. What, what I ended up doing. And I'll share. This is actually what I do second, but I'm, I'm sharing on screen. Oh, not working at the moment. Looks like I, looks like I have a small problem with my, my screen sharing. So I will not do that.Mitchell Levy [00:10:00]:I ended up interviewing 500 thought leaders on, on credibility. And with those 500, I was able to articulate the definition of credibility, which turns out to be a good operating system. We live by credibility is the quality which we TR light. And it turned out that I unlocked a superpower. My superpower is deploying the framework of clarity. So I sit with any company, any human, help them articulate in less than 10 words where they're executing on their purpose. Now, I call that a C pop. Your customer point of possibilities, that's, that's that north star.Mitchell Levy [00:10:36]:That's the compass we're talking about. And Stuart, let's create that view. I looked at your LinkedIn, looked at your website. There's nothing wrong with it. There's nothing wrong. What I will promise you is that after you hear your C pop, you're going to go, oh, I have to make changes because it's just going to help focus you right. Now let me say something and I'm going to guess right away. I'm going to guess that you're in a 10%.Mitchell Levy [00:11:03]:And I'll tell you what I mean by that. When I share a C pop with somebody, I'm they. We as humans, we vibrate out of frequency. And so what happens is the, the C pop represents in words, the frequency you vibrate at. It's who you are. It's, it makes you feel aligned with who you are. I've done this over 1200 times and in 1200 cases, the person's Feeling aligned. Now here's the scary part.Mitchell Levy [00:11:37]:In 90% of the cases, they will get unaligned between two hours and two weeks because of the chaos and noise out there. I'm going to assume that you're going to be in the 10%. So we'll see next time we talk.Stuart Webb [00:11:49]:Right.Mitchell Levy [00:11:52]:Now, I also will tell you something else. I will give you the formula. It's a secret formula. And I will gift that to you and we'll go through the exercise together. When I was doing the interviews, I created a video and I would share the formula and say, listen, what I found so far. I created the video somewhere around interview 50. And what I said, what I found so far is even when somebody had the formula, only 2% would actually articulate their C pop. Because even with the formula, it's hard because we get stuck on this marketing cookie cutter stuff.Mitchell Levy [00:12:30]:And even after they got the video, they. There was still only 2% of people could walk in. So I'm gonna give you. I'm gonna give you in the audience the formula and we'll walk through it together. The C pop is less than 10 words, and it's really two components. The first is the who. And I'm gonna go in and ask you the questions. Who do you serve? If we're credible, we're servant leaders.Mitchell Levy [00:12:55]:So who do you serve? And the second piece is from their perspective. What is their pain point? Or what is their pleasure point?Stuart Webb [00:13:04]:Right.Mitchell Levy [00:13:05]:So let me ask you these questions. So who is it that you serve?Stuart Webb [00:13:10]:So I serve a business leader who has a really bright idea but doesn't know how to get that and make it into a positive business reality.Mitchell Levy [00:13:20]:Now, it's funny because you're LinkedIn says founders.Stuart Webb [00:13:26]:That's true. It is true.Mitchell Levy [00:13:28]:So when you think about where 80% of your revenue comes from, is it from corporate businesses and business leaders, or is it from founders? Or who. Who is it?Stuart Webb [00:13:38]:It's 80% comes from founders.Mitchell Levy [00:13:41]:Okay, so good thing I looked at your LinkedIn. All right, so from the. I think you said it, but I'm going to ask you both pain and pleasure, what's their primary pain point?Stuart Webb [00:13:58]:They have no ability or starting point to make that business strategy or business idea an actual reality in the marketplace. They are unable to articulate, possibly even to themselves, where they start to go from. This would be brilliant to. It is there and it's making me money.Mitchell Levy [00:14:29]:So you're talking about really founders, pre revenue founders.Stuart Webb [00:14:34]:Now, a lot of the people that I deal with are. They've already Got a product, but they've got one product. They need two because they want to scale. And the problem they have is I've got a great idea for my second product, but the way I did it first, but now I've got a small team, it doesn't work the second time.Mitchell Levy [00:14:57]:Interesting. Okay, so they, they have money because they've, they've been able to get something in the marketplace, but now they want to scale. Either scale what they're doing or scale into another product.Stuart Webb [00:15:14]:Essentially, yes.Mitchell Levy [00:15:16]:Oh, oh, Tell me how to get it wrong. Tell me what you got.Stuart Webb [00:15:20]:No, no, no, you're absolutely right by saying essentially, yes. The only other thing that I would add into that is there are. There are sometimes businesses who have managed to get that second product, but it's now tanking because they have got all the wrong. They're trying to do it the way they did it before, and therefore, you know, the, the mechanisms they're using are wrong for where they are because they're now a bigger company. You were talking about politics. They're now sort of saying, it's got to be done by other people, but it's got to be done my way, in the way that I started this. And that just doesn't work if they start instructing in that way. Whilst we're doing this.Mitchell Levy [00:15:55]:While we're doing this, Mitchell, I know you're just doing a bit of typing, such like, I'd invite anybody. If anybody's hearing this and thinking to themselves, I need to make comments or I need to actually sort of, you know, leap in. At this point, Mitchell and I will be monitoring the comments on LinkedIn after this. So if you've got questions or if you're looking at this and thinking, I want somebody to talk to me about this, post your questions there. I can guarantee Mitchell will get onto that and we'll answer your questions because he's that sort of guy.Mitchell Levy [00:16:22]:Thank you, Will. Interesting. Okay, give me a pleasure point, not a pleasure point of working with you, but we'll just fast forward to a period of time after they've had a chance to spend time with you. How are they feeling? What are they doing? What. What makes sense to them?Mitchell Levy [00:16:41]:Let me give you a very real example of that. Working with a company, the founders needed to start to scale something. We turned their service that was poorly defined couldn't be delivered because they couldn't really articulate it. It's now much more of a sort of defined product idea, although it's still a service, but it's got a Logo. It's got a description, it's got a series of processes which their staff can operate, and they're selling that multiple times per week. And it's now. It's now. Then they're now proud of it.Mitchell Levy [00:17:18]:They're now saying, I'll use the name of it. They're now saying, threat sure is a great product. It was a great idea, and now it's something which is actually making us money. And customers love it.Mitchell Levy [00:17:32]:Cool. Nice. Okay, thank you. So yours is easy.Mitchell Levy [00:17:42]:I don't want it to be easy, Mitchell.Mitchell Levy [00:17:44]:Let me rephrase that. Yours was really simple. And it was only after I started talking to you to see who I was seeing this morning that I. Because, remember, we talked in the green room. Should we do this live? And sometimes there's a lot of marketing, cookie cutter stuff that gets in the way, but everything you said reinforced. Wait, let me count the words. 1, 2, 3, 4, 6 words. Would you be happy if you could describe yourself?Mitchell Levy [00:18:11]:Wow. Okay, that is now. I will say now. This is where people. If you are watching this live and if you are going to go onto LinkedIn, you need six words. I have never been able to articulate this in six years. Six words. I can articulate it in two or three hours if you ask me to.Mitchell Levy [00:18:26]:But six words, that's impressive.Mitchell Levy [00:18:28]:So let me. Let me say that. Or just say less than 10.Stuart Webb [00:18:34]:Right?Mitchell Levy [00:18:34]:Because if you. If you think about it, and, and this is. This is for people paying attention. When you asked me my two audiences, I gave you my seat, my two C pops. C POP stands for customer Pointed Possibilities. So my executive coaching is nine words. Inc. 5000 CEOs leading the future with executive abundance.Mitchell Levy [00:18:55]:The goal when you share your CPOP is that the referral partner or the prospect says, oh, tell me more, Mitchell, what's this executive abundance thing?Stuart Webb [00:19:02]:Right? Or.Mitchell Levy [00:19:04]:Or the other one when I'm talking to a business owner. By the way, Stuart, you're a business owner, right? So when I talk to your founders or business owners, When I talk to business owners, it's business owners escaping slimy LinkedIn sales tactics. And I either get the laugh that you gave before or the visual reaction because you just remember being slimed recently.Mitchell Levy [00:19:23]:Yeah. Yeah.Mitchell Levy [00:19:24]:In either case, the goal when I share those words or is to paint a compass, to paint a. A playground that I plan. And then when I answer what comes next, I get more credibility because I've been so finite in terms of the playground. So in your particular case, your playground is six words. And I'm Putting it in chat, because I'm a visual person, so you could see it as well. But I'll share it out loud. Founders needing a path to scale.Mitchell Levy [00:20:01]:Brilliant.Stuart Webb [00:20:02]:Right?Mitchell Levy [00:20:03]:And so, by the way, once again, anybody who is watching this, that is such a brilliant summary. I could not. I couldn't have done. I couldn't have done that without Mitchell's help. But that is a fabulous summary.Mitchell Levy [00:20:18]:I'm going to say thank you. And it's. By the way, it's you. Because, by the way, although what happened, you're marketing cookie cutter stuff, which I'm glad I looked at your LinkedIn. You said the word founders, and that seemed important to me, so I had to ask you, where does 80% of revenue come from? Yeah, right. And it's. But other than that, everything you said reinforced. And you already have this on your LinkedIn.Mitchell Levy [00:20:46]:You have a couple other things which I might encourage you to remove. But everything you said reinforced. Having a path to scale. Even the pleasure point was talking about a path to scale.Stuart Webb [00:20:59]:Right.Mitchell Levy [00:20:59]:And so when you now have these six words, and by the way, what I was typing in on the back end is, I have a Mitchell Levy chatbot, and I said, if this is your C pop, what could the acronym path stand for? And I'm putting it in chat. We don't have to talk about it, but this is just my gift for you. You know, path could stand for, you know, basically, purpose, action. Ooh, team, and. And. And harmony. Sorry, I. It didn't cut.Mitchell Levy [00:21:37]:It didn't cut and paste really well. And then it talks about what. That what stuff is. But. But I think. I think the way to think about it for you is, is when you share with somebody. Let me do your. Tell me more, if you don't mind.Stuart Webb [00:21:54]:I'll.Mitchell Levy [00:21:54]:I'll do it. Because we're recorded. Right, so. And now a superpower I have is the ability to do this. It's a formula, and I've just done it over 1200 times, so it's easy. I'm happy for people to grab it. It's the who and the what. Who in the what comes before why.Stuart Webb [00:22:12]:Right.Mitchell Levy [00:22:12]:Just to be clear. Comes before Simon Sinexy. Who in the what comes first? It's a C Pop. And a ancillary superpower is if I know somebody C Pop most of the time, I could do their tell me more better than them until they feel good about it. So let me tell you, Stuart, what I mean by this. When in the future, when you share your cpop now, if somebody says to you, hey, what's your cpop? Now, maybe a couple hundred thousand people know this word, so most likely they're gonna say, who are you?Stuart Webb [00:22:45]:Right?Mitchell Levy [00:22:46]:What do you do? Who are you? And in that particular case, you need to put a.Stuart Webb [00:22:51]:A.Mitchell Levy [00:22:51]:A hook up front. The hook is, hey, there's an audience I spend a lot of time with, or there's an audience I do really well with, or my clients all get success in a certain area.Stuart Webb [00:23:01]:Right.Mitchell Levy [00:23:02]:Whatever the hook is. Then you do a pause, and then you say, founders needing a path to scale. Then you drop the mic, and then you may say something. Oh, let me tell you a little bit more. Listen, I work with a series of founders. A lot of times they've already put their first product out there. They've already been successful, and they need to scale. They need to get to the next level, and they get stuck.Mitchell Levy [00:23:29]:They either don't know how to move forward or they've already moved forward, but they've deployed what worked in the first product to the second, and it doesn't work. What I do is help them lay out the path that will allow them scale going forward.Mitchell Levy [00:23:45]:Mitchell, that is the best way I have ever heard somebody describe what is effectively an elevator pitch. You'd have heard elevator pitch. And they're all. They're all very difficult for people to do, and most of the time, they're not very good. So I'm not going to say that, because there are a lot of people on here will be offended by that. But that.Mitchell Levy [00:24:04]:Oh, I'm gonna say it. I'm gonna say to you and everyone else, if you've memorized an elevator pitch, please forget it.Mitchell Levy [00:24:13]:Yes.Stuart Webb [00:24:15]:Right, stop.Mitchell Levy [00:24:15]:Now.Mitchell Levy [00:24:16]:It comes from here. Your elevator pitch comes from your head. And your goal when you talk to somebody is you want them to feel the energy inside. You want them to feel your heart. So memorize the six words or nine words or three. A couple people have three words, right? So memorize your C Pop. But you won't have to memorize it. It's your.Mitchell Levy [00:24:38]:It's your vibrational energy. And then your.Stuart Webb [00:24:40]:Your.Mitchell Levy [00:24:41]:What would have been your elevated pitch is more the tell me more. Which you custom tailor to the person you're talking to.Stuart Webb [00:24:47]:Yeah, absolutely. I love what you're saying. Look, Mitchell, I could keep you here for another couple of hours, but I have a feeling you have important business to go and speak to other people who need this. Once again, I'm going to invite anybody listening live or in future, when you see this, drop comments into the comments Below, Mitchell, I know, will come back, give you some very, very good advice to try and get this sort of thing into your life, because we need more clarity. I am, as Mitchell has probably managed to sort of convince me. I spend a lot of my time with people who haven't got the clarity they need. And it is always difficult to get that clarity because in their own head, they're trying to rationalize, they're trying to sort of apply a set of rules. You know, they've done all the courses, they've read all the books, they've.Mitchell Levy [00:25:43]:They've been out and seen all the YouTube videos, and somehow that's actually created less clarity than if they just sat down and did a very simple exercise like Mitchell is doing here. So drop your questions, drop your comments. I know we can get some clarity back in the world. But Mitchell, how did you get to this? Where did you come from that this became your mission in life?Mitchell Levy [00:26:07]:It's really interesting, I think, what happened because of time. I'll try to do this super quick. My undergraduate was a Bachelor of Science in Stochastic and Deterministic Models of Operational Research. In essence, I was taught how to model. Well, as long as I could say the words and the syllables come out of my mouth, I'm still happy. And one day I won't be able to do that anymore, right?Mitchell Levy [00:26:34]:So.Mitchell Levy [00:26:36]:But I was taught how to model people and systems and improve them. And what I learned then I got an MBA, and as I mentioned previously, I'm doing the PhD thing, right? So what. What I learned was, although I only speak English and it's American English, and so it's bad English, I don't speak those multiple languages. I do speak multiple languages of functions, you know, so marketing. Funny. Marketing, talking to sales, talking to engineers. I mean, it's just, whoever you are, I could speak your language because I'm feeling the energy of what does it mean to be who you are? And then it was in 2019 that I went on a Napoleon Hill journey And I interviewed 500 thought leaders on credibility between 2019 and 2020. And so I.Mitchell Levy [00:27:27]:It turns out I asked everyone five questions. And the first question that just sort of magically appeared to me is, what's your C Pop? That's the first thing I wanted to. I wanted to learn from people. And. And it took me a couple years, post the interviews, post the TED Talk, post the book that I wrote on it. By the way, I've written 65 books. My 66 is the most important. It's the one I'm writing now called Executive Abundance.Mitchell Levy [00:27:57]:It took a number of years afterwards to really understand. As a matter of fact, what happened is I went to the Purpose Summit. Now, when you go to a summit called the Purpose Summit, you got a lot of people talking about purpose, bringing purpose into corporations, what people's purpose are. And, you know, everyone had a different definition and it meant many different things to different people. And at some point in time, I thought the C pop had to do with purpose. But as it turns out, the C pop is where one is executing on their purpose today.Stuart Webb [00:28:30]:Yeah, brilliant, right?Mitchell Levy [00:28:32]:And I'm like, oh, my God. And then once that started happening, and then. I'll give you one last. One last thing. It was about seven months ago, eight months ago. So, by the way, if you haven't figured this out, being credible means you're always learning, you're always growing, you're always coachable.Stuart Webb [00:28:47]:Right?Mitchell Levy [00:28:49]:About seven, eight months ago, I realized something, and this put everything into perspective. I've known this my entire life. I've been in Silicon Valley, started 20 companies, and sat on the board of a public firm.Mitchell Levy [00:29:01]:And.Mitchell Levy [00:29:01]:And I've known this my whole entire life, but have not ever executed on it until about seven or eight months ago. Sell them what they want, deliver what they need.Stuart Webb [00:29:13]:Yeah, brilliant.Mitchell Levy [00:29:14]:So let me. I'll just finish that. So what's interesting is I ended up spending five and a half years of my life focused on what people need. Clarity and credibility are what people need. It's not what they want. So you sell them something else, but behind the scenes. So I'll make a. I'll make an offer for you.Mitchell Levy [00:29:31]:And listen, there are many people who actually sell clarity, and they could still use the CPOP and what they work. So I do, once a month, I do a clarity session. Have your clients come with your client to one of my clarity sessions. Have them get their CPOP and then do your thing and do your magic, right? And. And it's. It's the. It's the partnership thing that we've been taught not to spend time on and not to focus on. But, you know, if you can bring your client to get a C pop.Mitchell Levy [00:30:03]:And. And then all of a sudden, everything you do from then out in is so much easier. You know, just an offer, if that's interesting here.Mitchell Levy [00:30:12]:Brilliant. Mitchell, I am very aware that there must be a question that you are waiting for that you are begging me to ask, but I haven't yet asked, and I am obviously unable to articulate that question because I don't know what it is. So what's the question you think I should have by now asked? And then clearly you're gonna have to answer it because I haven't yet thought about.Mitchell Levy [00:30:35]:You know, that's always my favorite. That's my favorite question.Mitchell Levy [00:30:39]:It's the one. It's one I like best because I don't have to do any work for that one.Mitchell Levy [00:30:43]:Yeah, you know, I didn't really, given I'm looking at the time, I didn't really have anything. I guess the. Probably the biggest question is it's along the lines of, Mitchell, what you did with Stuart was so simple and so straightforward and so quick. Why is it that Stuart didn't already know that? Or why? Why? If you say you've done this 1200 times and every time they've had the same reaction with Stuart, how come you're not known universally around the world? That would probably be the answer.Mitchell Levy [00:31:30]:And the answer.Mitchell Levy [00:31:32]:I'm still, I'm still grokking. I'm still trying to grok all that.Stuart Webb [00:31:35]:Right.Mitchell Levy [00:31:35]:Still trying to figure that out. The, the. A lot of the answers. There are many people who, who focus on clarity and focus on credibility and, and I think ultimately it's the best way I could think about it now. It really is what people need, but not exactly what they want. What I found is that 90% of. Of. Of people, or let's even go down to the C pop level, 98 of people don't know their C pop.Mitchell Levy [00:32:14]:And if you ask them if they have clarity, they're either going to say yes or they're going to say, I don't care, I don't need it. But 98% of people, 98% of the audience has figured out that. That understanding where they're executing their purpose in less than 10 words is not important to them yet. And so it's hard to imagine that you could sit with somebody and they could look at you and they could. They could actually present a summarized version of how you're showing up in the world so quickly. And, you know, there are people who watch us who would think it's staged, that we did it ahead of time.Stuart Webb [00:33:00]:Right.Mitchell Levy [00:33:01]:And it's not. So. But the answer, I don't. I don't know exactly. I just know that when I talk to somebody, whether it's a CEO of a large company, if, if you're my client, I'm going to stick with you and you're going to play in your playground.Stuart Webb [00:33:15]:Right.Mitchell Levy [00:33:16]:But if you're somebody who I'm just Sort of giving a gift to or you're. You've paid me to be in my clarity session. The it, it's so easy to get off track. It's so easy to get out of alignment that people often do. And they go, yeah, it was good talking to Mitchell for a period of time, but I didn't do anything with it. Right when and, and what I'll say to you is last week was also, it was a great gift. It's when I advanced a candidacy for the PhD. I also had a woman join me and apparently I had talked to her three years, three years earlier.Mitchell Levy [00:33:56]:And the first words out of my mouth, out of her mouth was, Mitchell, I've been thinking about you for the last three years. Which is one of those things that are really, you know, you know, how do I interpret that? And she goes, I was about ready to enter an extremely difficult chapter of my life. And what you gave me, that C pop was the best gift I've ever received in my life because it allowed me to actually pull myself out of that chapter to focus on my business. And I've served 259 clients over a five year period. Most of those came after year two because that's when you and I spoke. And I am just so honored to have spent time with you. That's an example of somebody who heard it, understood it and used it. And I did.Mitchell Levy [00:34:54]:I challenge anyone. If you get your C pop and I'm someone who supports you or where you could take the formula in the 2% and you can make it work for you, I'm going to encourage you to live it and see what happens. I guarantee that your life will be different.Stuart Webb [00:35:10]:Mitchell, that is a brilliant story to end on. I've got nothing very much else to say. I'm going to ask people if they would just go to this link www.systemize.me subscribe. You need to go to that link because that link is a link to a form which will allow me to send you an email and you will then get an email once a week when we have brilliant guests like Mitchell on. And you can just sit and learn from people like Mitchell because they are worth listening to. Mitchell, you have been an inspiration. I have got some words to add to my LinkedIn profile, but better than that, I've got some living to do now because I have now got a challenge from you to live up to something that you have set down as a standard for me. I cannot believe what you do and you should be world famous and I'm going to try and make it so.Stuart Webb [00:36:05]:Mitchell, thank you so much for spending a few minutes with us. I really appreciate it.Mitchell Levy [00:36:09]:Oh, Stuart, my. My pleasure. I. I look forward to whatever our next conversation and seeing who you are the next time I have a conversation with you.Stuart Webb [00:36:19]:Terrific. Thank you. Mitchell. Mitchell, that. Get full access to It's Not Rocket Science! at thecompleteapproach.substack.com/subscribe

In this episode of Wine After Work, Bryce sits down with Elif Acar-Chiasson, P.E., founder of OPLE Leadership and former COO with over 30 years in the AEC industry. Elif built her consulting practice after living inside what she calls a "broken autonomy model." Brilliant engineers are promoted into leadership roles, then trapped in approval culture where every decision climbs uphill for permission. The leader becomes the bottleneck. The team stops growing. Everyone burns out. Together, Bryce and Elif unpack: • Why technical excellence and leadership requirements are often in conflict • The hidden addiction to approval and control inside engineering firms • Why autonomy is not "do whatever you want," but clear decision ownership with guardrails • How emotional intelligence supports decision-making under pressure • What stepping away from a COO role taught Elif about fit and courage • Why leading with both head and heart is not weakness but maturity • What competitive ballroom dancing at 50 revealed about starting over and discomfort Elif shares a systemic approach to leadership. Instead of coaching one overwhelmed leader in isolation, she looks at the entire decision architecture of a team. Who owns what? Where decisions stall. How trust is built or broken. Her core belief: the most critical structural integrity is not in buildings. It is in teams. About Elif: Elif Acar-Chiasson, P.E., is a Professional Engineer and founder of OPLE Leadership. After 12 years as an executive, including 8 as COO at CSRS/Westwood, she now works with technical professionals who are exceptional at their craft but struggling in leadership roles. She translates emotional intelligence into engineering frameworks and helps teams redesign how decisions are made so leaders are no longer the bottleneck. Originally from Istanbul, Turkey, Elif brings a multicultural lens to leadership and challenges the idea that "people skills" are separate from technical rigor.   https://www.elifchiasson.com/  

Elizabeth Goff, aka The Historical Gal, brings the Tudors to life, with 100 tales of gowns, gossip, and gory ends!Show NotesElizabeth Goff @TheHistoryGal  @thehistoricalgal@the_historical_gal on InstagramBloody, Brilliant TudorsCarol Ann Lloyd@shakeuphistoryhttps://carolannlloyd.com/ https://patreon.com/carolannlloydThe Tudors by NumbersCourting the Virgin QueenHistory reveals what's possible.Support the showHistory reveals what's possible.

What truly drives innovation?Brilliant ideas… or the courage to think differently?In the upcoming episode of Empowering Yourself, host Sandy sits down with expert Andrew Tallents to explore how leaders and organizations can build a culture where creativity thrives.From psychological safety to learning from failure, this conversation dives into the real foundations of innovation.In this episode, we explore• Whether innovation is a skill or a natural talent • How leaders can create workplaces where bold ideas are welcomed • Why failure is an essential part of creativity • How to balance structure with experimentation • Simple ways teams can generate fresh ideasBecause innovation is not a moment. It is a mindset practiced every day.Episode coming soon on Empowering Yourself. Stay tuned.

Jeannette talks to the powerhouse that is Amber Hollingsworth, who shares her insights on addiction, drawing from her extensive experience as a counselor and founder of "Put The Shovel Down" and "Hope Stream Community."  The conversation delves into the complexities of addiction, including the distinction between functional addicts and those in denial, and the impact of addiction on families and workplaces. Amber discusses her unique approach to helping families communicate effectively with loved ones struggling with addiction, emphasising the importance of understanding and connection over confrontation You'll Learn Why: Addiction can manifest in various forms, including substance use disorders, and affects not just the individual but their entire support network. Family members often play a crucial role in addressing addiction.  Instead of confronting the individual directly about their problem, it's more effective to approach the situation collaboratively The belief that individuals must hit rock bottom before seeking help is misleading.  Many people continue their addictive behaviours despite severe consequences Having a clear sense of purpose is vital for both individuals struggling with addiction and those helping them This episode is living proof that no matter where you're starting from — or what life throws at you — it's never too late to be brave, bold, and unlock your inner brilliant. Visit ⁠https://brave-bold-brilliant.com/⁠ for free tools, guides and resources to help you take action now

Ger Gilroy, Vinny Perth and Dara Smith-Naughton bring you all the talking points on a Tuesday that marks the return of the Champions League with 4 matches this evening. Last night Shelbourne and Shamrock Rovers faced off at Tolka Park with both sides coming away with only a point. Viagra Connect 50mg film-coated tablets. Contains sildenafil. For adult men with erectile dysfunction. Subject to suitability. Maximum dosage one 50mg tablet per day. Always read the label. Catch The Off The Ball Breakfast show LIVE weekday mornings from 7:30am or just search for Off The Ball Breakfast and get the podcast on the Off The Ball app. SUBSCRIBE at OffTheBall.com/join Off The Ball Breakfast is live weekday mornings from 7:30am across Off The Ball

Sparks fly when 9-year-old pianist Alexander Zhou takes the keys. Orli Shaham hosts this episode where we also hear from a teenage violist performing Rebecca Clarke's beautiful viola Sonata.To manage podcast ad preferences, review the links below:See pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

In this episode, you'll learn: Why expert advice feels so seductive during high-stakes decisions What a “context swap” is and how it silently creates strategic damage The three patterns of the External Wisdom Trap: The Credential Override The Proof Point Illusion The Wisdom Surrender How to filter outside expertise through your own organizational reality The difference between adopting advice and adapting wisdom The powerful leadership question:“What would have to be true for this to work here?” Key Insight: The most effective leaders do not eliminate outside input. They develop the discernment to know what applies to their specific situation and what does not. Resources Mentioned: Think First: Unlock the Possibilities Others Miss Reserve your copy at: deliberate directions dot com/thinkfirst Think First

Are some of the greatest science fiction books ever written… “unpublishable” today?In this episode of Fantasy for the Ages, we explore classic sci-fi masterpieces that might struggle to get published in today's market—not because they're bad, but because publishing trends have changed.Classic science fiction often focused on big ideas: philosophy, sociology, religion, artificial intelligence, the future of humanity, and massive conceptual worldbuilding. Many of these stories were episodic, idea-driven, experimental in structure, or deeply philosophical—things that modern publishing sometimes finds harder to market.So what would happen if these legendary books landed on a publisher's desk in 2026?Would editors ask for:• faster pacing?• stronger central protagonists?• fewer philosophical digressions?• clearer genre hooks?Today we're looking at 11 classic sci-fi books and series that might not get published today—but absolutely should. These works helped shape the entire science fiction genre, influencing generations of writers, filmmakers, and readers.But would they make it through the modern publishing process today?Let's talk about it.⸻

In the second part of our diamond series, we turn from science to history. After exploring how diamonds form and how they are cut in Part I, this episode follows the extraordinary journey of the diamond through human history. From the ancient riverbeds of India to the great discoveries in Brazil and South Africa, we trace how diamonds moved across continents, empires and centuries. Along the way we explore how diamond cutting evolved from simple polishing of natural crystals to increasingly sophisticated faceting techniques that transformed the stone's beauty. From the earliest point cuts and table cuts to the rose cut, old mine cut and the beginnings of the modern brilliant, each development reflects changing technology, taste and the growing desire to unlock the diamond's brilliance. This is the story of how a rare natural curiosity became one of the most important gemstones in jewellery history. In the next episode of this series, we'll turn to one of the most mysterious diamonds ever known - the legendary Florentine. If you enjoyed the episode, make sure you're subscribed wherever you listen to podcasts, and if you have a moment please leave us a rating or review on Spotify or Apple Podcasts. www.courtville.ie Get social with Courtville, follow us on Instagram, Facebook, and TikTok This podcast was produced for Courtville by Tape Deck

It's still time for another BIG and BRILLIANT adventure into the world of science on this week’s Science Quest! In Science in the News, NASA is rethinking its plans for landing astronauts on the Moon, scientists believe the history of writing might be thousands of years older than we once thought, and Frederick Wilkinson from Queen Mary University of London explains why a recent boom in sea turtle numbers might not be quite as good news as it sounds. It’s time for your questions too. Akiva wants to know why your tummy gets smaller when you breathe in, and John Bridges from Leicester University answers Nicolas' question: How are asteroids made? Dangerous Dan introduces us to something a little different this week: the super-Earth exoplanet TOI-1452b, a strange and fascinating world far beyond our Solar System. Then in Battle of the Sciences, Mark Grabowski from Liverpool John Moores University steps into the ring to make the case for palaeoanthropology, the science that studies ancient humans and our evolutionary ancestors. Plus, Harry and Terry stumble across the asteroid belt in this week’s Space Cadets adventure as they continue their accidental journey through space. What do we learn about? How asteroids form in space Why NASA is changing its plans for Moon missions Why the history of writing might be older than we thought Why a sea turtle population boom may not be entirely good news What happens to your body when you breathe in The strange super-Earth exoplanet TOI-1452b How scientists study ancient humans and our ancestors All that and more on this week’s Science Quest!Join Fun Kids Podcasts+: https://funkidslive.com/plusSee omnystudio.com/listener for privacy information.

Brilliant!See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this very special recording Jeannette finds herself in an entrepreneur panel powerhouse, moderating an impactful, insightful conversation from the Festival Of Entrepreneurs Together, they pull back the curtain on the gritty reality of scaling a startup into an international brand, discussing everything from the necessity of regulatory compliance to the emotional resilience required to survive the "frogs" and rejections of the fundraising world. You'll Learn Why: Starting with full regulatory compliance from day one is essential for businesses in regulated industries Understanding your unit economics, cost to market, and customer spend is non-negotiable Successful fundraising often requires kissing a lot of frogs, with some founders reporting a 98% rejection rate In new categories, founders must move away from having all the answers and instead remain flexible This episode is living proof that no matter where you're starting from — or what life throws at you — it's never too late to be brave, bold, and unlock your inner brilliant. Visit ⁠https://brave-bold-brilliant.com/⁠ for free tools, guides and resources to help you take action now

Nottingham Forest put in a great performance to ease their relegation fears with a 2-2 draw against Manchester City in the Premier League on Wednesday night thanks to great goals from Morgan Gibbs-White and Elliot Anderson. Matt Davies is joined by Mark Sutherns and Simon Fotheringham to discuss the game in full. #nffc #nottinghamforest

The lads are back from Kieran's stag weekend in Belfast. Hear about their wild and wonderful adventures in the NIFL over the past few days. Meanwhile, back in the League of Ireland, Bohs are looking good, could they compete for the title? The James McClean midfield experiment is off to a rocky start, while it's been another tough week for Kevin Doherty, Drogheda United, and Sligo Rovers. Drogheda United's punishment for the unrest in the Louth derby and the FAI's plans to change licensing requirements around pyro also feature. WHAT THE HELL IS A PYRO DOG! All of these talking points and much more are included on this week's pod, which as ever is sponsored by QuinnAv.ie and BAR 1 Betting (18+, gamblingcare.ie)

It's time to get introduced to one of the most powerful apologetics arguments against atheism: Alvin Plantinga's Evolutionary Argument Against Naturalism. For further reading: What Is the “Evolutionary Argument Against Naturalism?” by Joel Settecase https://settecase.wordpress.com/2018/06/27/what-is-the-evolutionary-argument-against-naturalism/==============================♱ SUBSTACK: Read weekly articles to help you learn and grow: https://thethinkinstitute.substack.com/♱ CHURCH TRAINING: Bring an IMPACTFUL weekend training event to your church or ministry ➡️ https://thethink.institute/forchurches♱ SOCIETY: Christian men get equipped for their Christian life, in community. Try out the Hammer & Anvil Society now. Go to https://thethink.institute/society.The easiest method for teaching your kids the faith we can help you learn (catechism): https://thethink.institute/catakids Men: Want to become the worldview leader your family and church need? We provide in-depth education and community for Christian men: https://thethink.institute/societyMy name is Joel Settecase. I'm the president of The Think Institute, NFP. How I got here: 2009: Left the business world.2010: Became a Bible teacher at a Christian school in Chicago. Realized I needed more education.2011: Enrolled at Trinity Evangelical Divinity School (TEDS). 2013: I joined a suburban church as pastor-in-training.2013–2016: Served as a youth pastor, discipling middle and high school students.2014: Wife diagnosed with cancer while pregnant. God taught us faith.2014–2015: Discovered Calvinism, New Covenant Theology, and Presuppositional Apologetics.2015: Our thirdborn diagnosed with leukemia. God tested and trained us in real time.2016: Joined Chicago multi-site church as Associate Pastor overseeing men's, students, and family ministry and evangelism—later becoming interim lead campus pastor.2016 Wrote Catakids! catechism to teach my young kiddos the faith.2017: Graduated cum laude from TEDS. Capstone papers on apologetics of Jonathan Edwards and John Frame.2018: Joined Cru Church Movements as missionaries.2019: Thirdborn got heart failure. God built our ministry from Lurie Children's Hospital.2020: Started homeschooling. Son received heart transplant. 2020: Launched the Hammer & Anvil Society during Covid.2021: Started teaching at homeschool co-ops.2022: Launched The Think Institute as a nonprofit.2023: Wrote The Bible Based Worldview. 2023: Re-launched the Hammer & Anvil Society as a nationwide men's fellowship. 2024: Joined Village Bible Church, teaching apologetics and worldview classes, family camps, men's retreats, student electives, and Sunday sermons.2025: Launched on Substack. YouTube channel hit 1M views. We now reach 75K+ people monthly and distribute hundreds of educational resources each year. To every Christian man trying to live a Christian life: God will give you what you need for your journey (Eph. 2:10). I am living proof of that. And now my job is to help you build a worldview legacy, where you, your kids, and your wife will be able to confidently answer the world's questions with confidence, and see Jesus change lives as you share your faith.===========================================================The Think Institute relies on the generous support of our Ministry Partners to pursue our mission. Thank you for your help in preparing thousands of regular believers to explain, share and defend the Christian message all over the world.The Think Institute, NFP is a registered 501(c)(3) non-profit organization (EIN: 88-3225438). Donations to The Think Institute are tax deductible to the fullest extent allowed by law.Donate now: https://thethink.institute/partner

Episode 228 of The Hitstreak, a podcast where we talk about anything and everything!  This week we are joined by Former MLB Pitcher, Cy Young Award Winner, Author, and Speaker, R.A. Dickey!Episode in a Glance:In this episode of The Hitstreak, I sit down with R.A. Dickey, a former professional baseball player, discussing his journey from overcoming personal adversity to achieving success in sports. Our conversation delves into themes of faith, family, and the lessons learned through the highs and lows of an athletic career. Dickey shares insights on the importance of embracing one's past, the role of relationships in personal growth, and the unique challenges faced by professional athletes. The episode concludes with reflections on gratitude and resilience in the face of life's challenges.Key Points:- Success stories often start from nothing.- Embracing your past can lead to freedom.- Faith is a skill that needs practice.- Family plays a crucial role in personal growth.- Professional sports teach valuable life lessons.- Gratitude is essential for happiness.- Proximity to positive influences matters.- Overcoming adversity shapes character.- Every setback can lead to a comeback.About our guest: R.A. Dickey is a former Major League Baseball pitcher, World Series champion, Olympian, and 2012 National League Cy Young Award winner, best known for resurrecting his career through mastery of the knuckleball. Drafted in the first round despite the early discovery that he was missing a ligament in his throwing arm, Dickey's career became a story of perseverance, reinvention, and faith. After years of setbacks, injuries, and uncertainty, he reinvented himself in his mid-30s—an age when most pitchers are declining—and became one of the most dominant and durable pitchers in baseball, leading MLB innings from 2011–2015. Beyond the field, Dickey is a bestselling author and sought-after speaker whose work centers on resilience, identity, accountability, and personal growth. His memoir Wherever I Wind Up chronicles his unconventional baseball journey and hard-earned success, while Wherever I Wind Up: My Quest for Truth, Authenticity, and the Perfect Knuckleball, plus Knuckleball Ned, reflects his passion for storytelling and mentorship. Dickey is widely respected for his vulnerability in addressing topics such as childhood trauma, leadership, and the cost—and reward—of doing the hard internal work required for lasting success. Grounded in discipline, honesty, and a belief that growth often comes through discomfort, R.A. Dickey's story resonates beyond sports, offering lessons on reinvention, endurance, and purpose.Follow and contact:Instagram: @RADickey43Subscribe to Nick's top-rated podcast The Hitstreak on Youtube: ⁠https://www.youtube.com/NickHite⁠rFollow and Rate us on Spotify: ⁠https://spotify.com/NickHiter⁠Follow and Rate us on Apple Podcast: ⁠https://podcasts.apple.com/NickHiter⁠Follow and Rate us on iHeartRadio: ⁠https://www.iheart.com/NickHiter

Jeannette to talks to Pablo Gomez, the CEO of Holafly, the global leader in eSIMs for travellers, to talk about the inspiring story of Holafly's journey, from its humble beginnings to its current status as a leader in the digital eSIM market.  They examine the importance of staying connected while traveling, the challenges of scaling a startup, and the personal reflections that drive Pablo's leadership style, focussing on the significance of aligning business missions with personal values and the transformative impact of technology, particularly AI, on the future of travel and connectivity You'll Learn Why: Their service addresses the modern traveler's need for reliable connectivity, which has become essential rather than a luxury. The focus remains on enhancing the customer experience Moving from CFO to CEO involves a significant shift in responsibilities, requiring a broader perspective on the entire organisation Personal experiences, such as overcoming a life-threatening accident, can profoundly shape one's perspective on life and career This episode is living proof that no matter where you're starting from — or what life throws at you — it's never too late to be brave, bold, and unlock your inner brilliant. Visit ⁠https://brave-bold-brilliant.com/⁠ for free tools, guides and resources to help you take action now

Part 2 of the Ben Bransby chat. Talking about losing his dad on an expedition, Patagonia, Leeds, Chris Wentworth, family and mental illness, not climbing all of Stanage. Brilliant.

In today's Cloud Wars Minute, I break down Aneel Bushri's powerful case for pairing AI with enterprise apps. Highlights 00:02 — There are some wild things going on in the enterprise software business, some of it rational, much of it irrational. But the big issue right now is for customers, partners, and the software vendors, the Cloud Wars Top 10, to figure out what is going to be the right way forward, the optimal mix of AI with enterprise applications. 01:47 — I think the most important thing here was his [Workday CEO Aneel Bushri] take on the interplay between apps and AI. And also, he just had an utterly classic line about vibe coding. He said there is no amount of vibe coding that will ever produce an HR or ERP system that will meet all the requirements that modern business needs. 02:25 — "Whatever your problem is, AI is the solution." That's just not true. It's a tool. It's a fabulous tool. Might be the most important tool ever, but it can't do everything. And in his opening remarks on the Workday Q4 earnings call, Aneel Bushri did a great job of breaking that down. 04:08 — He said the combination of AI and many of the things it can do with its probabilistic capabilities and insights and predictive capabilities, plus the deterministic certainty of enterprise apps, is a really nice pair. He talked about the way forward and how he sees those two dynamics playing together. 05:18 — I just think he did one of his best jobs ever yesterday to step forward and say: "Here's what's real. Here's what isn't real. Here is the way forward. Here's the best combination for things. Here's the right outcome for customers." Brilliant performance by him on this earnings call. Visit Cloud Wars for more.

Send a textAndrew Brilliant, of world time attack fame and beyond, joins me to talk about aero myths in club racing... and what we can do to better our downforce where rules allow. Yes, we even talked about rules... because I just had to bring it up. Support the show

Max Hastings reports that historians emphasize the disorientation of landings, where survival often depended on a few heroic individuals amidst the brilliant but flawed logistics of the Allied planners. 12.1944 SWORD

It's still time for another BIG and BRILLIANT adventure into the world of science on this week’s Science Quest! In Science in the News, a rare turtle rescued in the UK begins the next stage of its recovery, scientists discover that snakes don’t get hungry in the same way humans do, and archaeologist Nataša Sarkic joins Dan to investigate the remains of a so-called “vampire” found in a grave at Račesa, a fortress in eastern Croatia. It’s time for your questions too. Leo wants to know how chameleons change colour, and Simon Green from the Open University answers Roscoe’s big space question: just how hot is the Sun’s core? Dangerous Dan introduces the bizarre hag moth, and in Battle of the Sciences, we head beneath the ice with glaciologist Sammie Buzzard from the UK Centre for Polar Observation and Modelling to uncover what glaciers can teach us about our planet. Plus, in Space Cadets, Harry and Terry blast off on an accidental adventure to the Sun to discover more about the star at the centre of our Solar System. What we learn about: How rescued sea turtles recover Why snakes don’t feel hunger like humans The truth behind a “vampire” burial in Croatia How chameleons change colour How hot the Sun’s core really is The unusual hag moth What glaciologists study beneath the ice All that and more on this week’s Science Quest!Join Fun Kids Podcasts+: https://funkidslive.com/plusSee omnystudio.com/listener for privacy information.

Welcome to The Reel Schmooze with ToI film reviewer Jordan Hoffman and host Amanda Borschel-Dan, where we bring you all the entertainment news and film reviews a Jew can use. In today's Oscar-themed episode, movie maven Hoffman begins with a rant against the cynical social media uproar over a misstepped statement made at the Berlin Festival. We then hear about the 2025 hit "Blue Moon," which portrays a pivotal night in the life of master lyricist Lorenz Hart. The film is up for two Academy Awards, but one of our team would not give it the time of day again. Next, we turn to a 14-minute animated film called "Papillion," which captivated the pair. It is a painterly immersive dive into the life of Alfred Nakache, who competed in the 1936 Berlin Olympics in Nazi Germany, only to end up in Auschwitz that is one of five films competing for best short animation. Check out the "oy," the "meh" and "not bad" marks given to these films in this week's The Reel Schmooze. The Reel Schmooze is produced by Ari Schlacht and can be found wherever you get your podcasts.See omnystudio.com/listener for privacy information.

Send a textWelcome back to the Back in Time Brothers Radio Show, where your hosts DJ Paulie and Lou bring you 40 years of pop culture straight from the record crates to your ears!This week, we are digging through the bargain bins to bring you "Diamonds in a Dumpster"—a hilarious and nostalgic look at the absolute worst albums released by legendary artists, and the one redeeming track that managed to survive the wreckage.In this jam-packed episode, we're serving up an incredible variety of retro goodness:The Top 10 Countdown with Brit: We spin the "best of the worst" tracks from brilliant bands who completely missed the mark. Hear the chaotic backstories and the lone musical gems from Aerosmith's Nine Lives, The Rolling Stones' Dirty Work, Kiss's Unmasked, David Bowie's Never Let Me Down, and the disastrous Gary Cherone era of Van Halen.Rock Talk with Todd Snyder: Take a deep dive down the rabbit hole of the most expensive and delayed rock album in history—Guns N' Roses' Chinese Democracy. Todd breaks down the insane 15-year, $13 million production that included a dog-poop-scented chicken coop for guitarist Buckethead, a spiritual "aura" reader, and a disastrous Dr. Pepper giveaway.Movies Retro Style: DJ Paulie and Lou go head-to-head debating the best and worst actors to ever portray iconic movie characters. Find out who reigns supreme (and who failed miserably) playing Willy Wonka, Jack Ryan, Catwoman, Freddy Krueger, Robin Hood, and The Joker.TV Time: We take a hilarious look at the worst television shows ever made that were canceled after just one single episode. You won't believe some of these premises, including a 1990 British sitcom with a jaw-droppingly offensive historical premise that was immediately yanked from the airwaves.Busted! & Random Facts: As always, we kick things off with a roundup of the world's dumbest criminals—including a car thief who got caught because he was too busy playing Grand Theft Auto, and a diamond thief whose own coughing fit betrayed him. Plus, stick around for mind-blowing retro trivia about The Matrix digital rain, George Washington's real teeth, and the irony of ZZ Top.Forget where you are, remember where you were, and turn up the volume. It's time to go back in time!Support the showThanks for listening. Join us each Monday at 1pm Central at www.urlradio.net and follow us on Facebook!

Send me a DM here (it doesn't let me respond), OR email me: imagineabetterworld2020@gmail.comToday I'm honored to introduce you to: Brilliant and renowned American stand-up comedian, Emmy Award and Peabody Award Winner, podcast host and co-host, content creator, writer, wearer and finder of hilarious costumes, former GATE kid, loving husband to a dolphin, whistleblower to whistleblowers, survivor advocate, and someone I'm honored to call a friend: Kurt Metzger A comedian who turned personal rebellion into a beacon of unfiltered truth, Kurt's early life was anything but ordinary. Born in Ohio, he was raised in the Jehovah's Witness faith where he was ordained as a minister at age 17. Diving headfirst into stand-up, Kurt honed his craft in the gritty clubs of Philadelphia and New York, where his sharp wit and no-holds-barred style quickly set him apart in the industry. Kurt doesn't just write; he performs - showcasing his mastery of observational comedy laced with dark humor, tackling everything from politics to human folly. In addition to doing stand-up he also hosts his own podcast on YouTube and co-hosts with Jimmy Dore on The Jimmy Dore Show. A couple years ago, I crossed paths with Kurt on social media and learned that Kurt wasn't merely a fan of survivor testimonies - he was devouring them, using every raw testimony to finally piece together the puzzle of his own upbringing and defect from the Jehovah's Witness cult that had shaped (and scarred) his childhood. Those same accounts also helped paint a bigger picture of why the JW's may have the largest settlement in history against them for covering up sexual abuse crimes.  On his most recent appearance on Joe Rogan, Kurt even arrived dressed as the infamous MK ULTRA scumbag John C. Lilly - the dolphin-obsessed "scientist" survivors like J.R. Sweet have named as a programmer and abuser, talked about MONARCH and mind control on the show, brought and showed JR Sweet's incredible memoir, “Mormon Monarch” on the podcast, and left a signed copy of JR's book for Rogan after the podcast. What I love about Kurt is that he chooses advocacy over approval, values justice more than likes, and truth more than comfort. He delivers the hardest realities wrapped in his signature blend: razor-sharp comedy, biting sarcasm, gut-punch honesty - and laughter that disarms just enough for the truth to sink deep, refusing to fade when the jokes end. Today, Kurt has become a force of nature, a towering voice for survivors. He befriends them, amplifies their testimonies, shares their work, and fights publicly in ways few have the guts to match. In an era where even seasoned journalists and hosts hesitate to utter "MK ULTRA" or "crimes against humanity," Kurt sprinted toward the fire the instant he understood its scale - and that it's still burning.CONNECT WITH KURP: YouTube: https://www.youtube.com/@kurtmetzgercomedyIG: https://www.instagram.com/kurtmetzgercomedy/X: https://x.com/kurtmetzgerCONNECT WITH EMMA:YouTube: https://www.youtube.com/@imaginationpodcastofficialRumble: https://rumble.com/c/TheImaginationPodcastEMAIL: imagineabetterworld2020@gmail.com OR standbysurvivors@protonmail.comMy Substack: https://emmakatherine.substack.com/BUY ME A COFFEE: https://www.buymeacoffee.com/theimaginationVENMO: @emmaSupport the show

Yitzi Snow has created a masterpiece of a crossword: perhaps it's not hanging at the Louvre yet, but we know it'll get there someday. Why, you ask? For three main reasons:ThemeThemeThemeOh, and one more thing:Theme.

Jeannette challenges you to stop drifting and start deciding, offering a high-octane 90-day roadmap to radically reinvent your career and business. By breaking the quarter into three surgical phases—Clarity, Rebuild, and Amplify—she provides the structure needed to swap your six-figure mindset for an eight-figure reality while overcoming the inevitable discomfort of growth.  It's a call to arms for leaders ready to ditch the complexity, fix their bottlenecks, and claim their authority with focused, ruthless execution. You'll Learn Why: 90 days is the magic window for transformation Reinvention starts with a ruthless audit in the first month Most entrepreneurs fail by trying to change everything at once Momentum is fuelled by bold execution in the final 30 days Growth is inherently uncomfortable, and true reinvention requires saying goodbye to old versions of yourself This episode is living proof that no matter where you're starting from — or what life throws at you — it's never too late to be brave, bold, and unlock your inner brilliant. Visit ⁠https://brave-bold-brilliant.com/⁠ for free tools, guides and resources to help you take action now

Nadine Epstein says about Moment magazine, "Our goal is to encourage and nurture forbidden conversations that bridge chasms, exploring subjects that others often avoid or oversimplify through open-minded dialogue." Celebrating its 50th anniversary, we were curious to hear what the editor in chief of one of the highest regarded Jewish publications has to say about antisemitism, Israel, and how to deal with the mounting tensions. Join us.X: @NadineEpsteinDCX/IG: @MomentMagazineBook: RBG's Brave and Brilliant women - https://a.co/d/0b7jFL35WHAT IS THEJEWFUNCTION - A 10min EXPLANATIONhttps://youtu.be/5TlUt5FqVgQLISTEN TO THE MYSTERY BOOK PODCAST SERIES:https://tinyurl.com/y7tmfpesSETH'S BOOK:https://www.antidotetoantisemitism.com/FREE AUDIOBOOK (With Audible trial) OF THE JEWISH CHOICE - UNITY OR ANTISEMITISM:https://amzn.to/3u40evCLIKE/SHARE/SUBSCRIBEFollow us on Twitter/Facebook/Instagram @thejewfunctionSUPPORT US ON PATREONpatreon.com/thejewfunction

The phones are ringing and the callers are NOT holding back. Tonight's After Dark kicks off with a full-blown roast of the Chicago Bears and their fans' endless excuses for empty seats — turns out "there's so much to do in Chicago" doesn't hold up when your team might be moving to Hammond, Indiana. That "stupid piece of paper" Packers fans hold doesn't seem so stupid now, does it? The show takes a more serious turn as callers and Ryan reflect on the tragic losses within the Minnesota Vikings organization and the broader mental health struggles NFL players face when their identity is stripped away by injury or decline — from Jaire Alexander to Romeo Doubs to Christian Watson, the emotional toll of the league is real and worth talking about. Callers also dive into the special teams coordinator search and whether the Packers are willing to sacrifice offensive or defensive practice time to fix the unit, the backup quarterback debate and whether "planning to lose" without a quality backup is a fireable offense, one caller's passionate plea for Ryan to get a press pass, and a quick detour into why nobody's been talking about the Winter Olympics. This episode is brought to you by PrizePicks! Use code PACKDADDY to get started with America's #1 fantasy sports app. https://prizepicks.onelink.me/LME0/PACKDADDY To advertise on this podcast please email: ad-sales@libsyn.com Or go to: https://advertising.libsyn.com/packernetpodcast Help keep the show growing and check out everything I'm building across the Packers and NFL world: Support: Patreon: www.patreon.com/pack_daddy Venmo: @Packernetpodcast CashApp: $packpod Website: https://nfldraftgrades.com/ My Board: https://nfldraftgrades.com/board/83a18c42-7a0b-4590-8d1b-453e49840d02            

The phones are ringing and the callers are NOT holding back. Tonight's After Dark kicks off with a full-blown roast of the Chicago Bears and their fans' endless excuses for empty seats — turns out "there's so much to do in Chicago" doesn't hold up when your team might be moving to Hammond, Indiana. That "stupid piece of paper" Packers fans hold doesn't seem so stupid now, does it? The show takes a more serious turn as callers and Ryan reflect on the tragic losses within the Minnesota Vikings organization and the broader mental health struggles NFL players face when their identity is stripped away by injury or decline — from Jaire Alexander to Romeo Doubs to Christian Watson, the emotional toll of the league is real and worth talking about. Callers also dive into the special teams coordinator search and whether the Packers are willing to sacrifice offensive or defensive practice time to fix the unit, the backup quarterback debate and whether "planning to lose" without a quality backup is a fireable offense, one caller's passionate plea for Ryan to get a press pass, and a quick detour into why nobody's been talking about the Winter Olympics. This episode is brought to you by PrizePicks! Use code PACKDADDY to get started with America's #1 fantasy sports app. https://prizepicks.onelink.me/LME0/PACKDADDY To advertise on this podcast please email: ad-sales@libsyn.com Or go to: https://advertising.libsyn.com/packernetpodcast Help keep the show growing and check out everything I'm building across the Packers and NFL world: Support: Patreon: www.patreon.com/pack_daddy Venmo: @Packernetpodcast CashApp: $packpod Website: https://nfldraftgrades.com/ My Board: https://nfldraftgrades.com/board/83a18c42-7a0b-4590-8d1b-453e49840d02            

Lethal Mullet Podcast: Season Nine: Episode #301: Robin Hood Prince of Thieves  Season Nine is here, and the return of the Mullet. On tonight's episode: we look at the classic Robin Hood film Prince of Thieves, directed by Kevin Reynolds and starring an all star cast left by Kevin Costner. Brilliant film. #RobinHoodPrinceOfThieves  Robin Hood Prince of Thieves ️ Kevin Costner as Robin  ️ Alan Rickman as the Sheriff of Nottingham ️ Mary Elizabeth Manstrantonio as Maid Marian  TUNE IN to FPN on fpnet.podbean #FandomPodcastNetwork   send us your comments on ROBIN HOOD below    #lethalmulletpodcast #FandomPodcastNetwork

Gregory Zuckerman introduces the brilliant, driven scientists pursuing vaccines for AIDS, cancer, and malaria, who pivoted their controversial methodologies to confront the burgeoning COVID-19 pandemic. 3

It's still time for another BIG and BRILLIANT adventure into the world of science on this week’s Science Quest! In Science in the News, could an elephant foot bone discovered in Spain be evidence of Hannibal’s legendary war elephants? A teacher in Wales has an ancient crocodile species named after him by a former pupil, and Saturday 21st February is World Pangolin Day, and to celebrate, Dan chats with Jessie Schrauger from the Pangolin Conservation and Research Foundation about the vital work being done to protect the world’s most trafficked mammals. It’s time for your questions too. Isabel wants to know how lenses in glasses help us see clearly, and Luke Gaskill from Scout Adventures answers Marcus’ burning question: why is there smoke when there is a fire? Dangerous Dan introduces the strange and subterranean purple frog. And in Battle of the Sciences, Ian Mills makes the case for dentistry and the science behind keeping our teeth strong. Plus, in Professor Hallux’s Map of Medicine, we investigate toothache and discover what really happens if you forget to brush. What we learn about: Why fire creates smoke How lenses in glasses bend light Why brushing your teeth prevents cavities Possible evidence of Hannibal’s war elephants How pangolins are being protected The unusual purple frog What causes toothache All that and more on this week’s Science Quest!Join Fun Kids Podcasts+: https://funkidslive.com/plusSee omnystudio.com/listener for privacy information.

With Resident Evil Requiem around the corner, the Access gang are chatting about brilliant sequels that somehow surpassed their incredible predecessors. Join us as we share our favourite sequels, and discuss what we think makes a great sequel. What are your favourite videogame sequels? Let us know in the comments!PlayStation Access is the official YouTube channel of PlayStation UK - a vibrant, welcoming community celebrating all things PlayStation. Join us for gaming livestreams, list features and in-depth coverage on all your favourite games. Hosted on Acast. See acast.com/privacy for more information.

On a special BONUS episode we're talking to our old friends and the hosts of the BRILLIANT podcast You Might Know Her From! Not only is the SEVENTH season of their show premiering next Thursday, but Damian and Anne have a big LIVE show in New York on Saturday the 28th with (former Couples Therapy guest) Annaleigh Ashford and more, so if you live in NYC, get your tickets here and GO! Now, we've known Damian and Anne for probably a decade and a half, but we use today's episode to find out some things that don't come up when you're just hanging around watching Selena (1997). They both tell us about their mental health journeys, how the last ten years have put a lot of things into perspective relationship-wise, Anne tells us how she ditched her "despised therapist", Damian tells us about his dating life in middle age and OF COURSE, we discuss "The Breezeway Theorem" (?)! PLUS, obvi, we answer YOUR advice questions! If you'd like to ask your own advice questions, call 323-524-7839 and leave a VM or just DM us on IG or Twitter!Andy's latest essay can be found here! Also, we're in culture critic and Vulture writer Sean Malin's book The Podcast Pantheon: 101 Podcasts That Changed How We Listen!ALSO BUY A SUPER CUTE "Open Your Hearts, Loosen Your Butts" mug! And:Support the show on Patreon (two extra exclusive episodes a month!) or gift someone a Patreon subscription! Or get yourself a t-shirt or a discounted Quarantine Crew shirt! And why not leave a 5-star review on Apple Podcasts? Or Spotify? It takes less than a minute! Follow the show on Instagram! Check out CT clips on YouTube!Plus some other stuff! Watch Naomi's Netflix half hour or Mythic Quest! Check out Andy's old casiopop band's lost album or his other podcast Beginnings!Theme song by the great Sammus! Hosted on Acast. See acast.com/privacy for more information.

Melissa Lavasani & Jay Kopelman join our podcast to discuss how psychedelic policy is actually moving in Washington, DC. Lavasani leads Psychedelic Medicine Coalition, a DC-based advocacy organization focused on educating federal officials and advancing legislation around psychedelic medicine. Kopelman is CEO of Mission Within Foundation, which provides scholarships for veterans and first responders seeking psychedelic-assisted therapy retreats, often outside the United States. The conversation centers on veterans, the VA, and why that system may be the first realistic federal pathway for psychedelic care. Early Themes Lavasani describes PMC's work on Capitol Hill, including hosting events that bring lawmakers, staffers, and advocates into the same room. Her focus is steady engagement. In DC, progress often happens through repeated conversations, not headlines. Kopelman shares his background as a Marine and how his own psychedelic-assisted therapy experience led him to Mission Within. The foundation has funded more than 250 scholarships for veterans and first responders seeking treatment for PTSD, mild traumatic brain injury, depression, and addiction. They connect this work to pending veteran-focused legislation and explain why the VA matters. As a closed health system, the VA can pilot programs, gather data, and refine protocols without the pressures of private healthcare markets. Core Insights A recent Capitol Hill gathering, For Veteran Society, brought together members of Congress and leaders from the psychedelic caucus. Lavasani describes candid feedback from lawmakers. The message was clear: coordinate messaging, avoid fragmentation, and move while bipartisan interest remains. Veteran healthcare is not framed as the final goal. It is a starting point. If psychedelic therapies can demonstrate safety and effectiveness within the VA, broader adoption becomes more plausible. Kopelman raises operational realities that must be addressed: Standardized safety protocols across providers Integration support, not medication alone Clear training pathways for clinicians Real-world data beyond tightly screened clinical trials They also address recent negative headlines involving ibogaine treatment abroad. Kopelman emphasizes the need for shared learning across providers, especially when adverse events occur. Lavasani argues that inconsistency within the ecosystem can slow federal confidence. Later Discussion and Takeaways The discussion widens to federal momentum around addiction and mental health. Lavasani notes that new funding initiatives signal growing openness to innovative treatment models, even if psychedelics are not named explicitly in every announcement. Both guests stress that policy moves slowly by design. Meetings, follow-ups, and relationship building often matter more than public statements. For clinicians, researchers, operators, and advocates, the takeaways are direct: Veterans are likely the first federal pathway Public education remains essential Safety standards must be shared and transparent Integration and workforce development need attention now If psychedelic medicine enters federal systems, infrastructure will determine success. Frequently Asked Questions What do Melissa Lavasani & Jay Kopelman say about VA psychedelic policy? They argue that veteran-focused legislation offers a realistic first federal pathway for psychedelic-assisted care. Is ibogaine currently available through the VA? No. They discuss ibogaine in the context of private retreats and future possibilities, not an existing VA program. Why do Melissa Lavasani & Jay Kopelman emphasize coordination? Lawmakers respond more positively when advocates present aligned messaging and clear priorities. What safety issues are discussed by Melissa Lavasani & Jay Kopelman? They highlight the need for standardized screening, monitoring, integration support, and transparent review of adverse events. Closing Melissa Lavasani & Jay Kopelman provide a grounded look at how psychedelic policy develops inside federal systems. Their message is practical: veterans may be the first lane, but long-term success depends on coordination, safety standards, and sustained engagement. Closing This episode captures a real-time view of how federal policy could shape the next phase of the psychedelic resurgence, especially through veteran-facing legislation and VA infrastructure. Melissa Lavasani & Jay Kopelman argue that coordination, public education, and shared safety standards will shape whether access expands with credibility and care. Transcript Joe Moore: [00:00:00] Hello everybody. Welcome back to Psychedelics Today. Today we have two guests, um, got Melissa Sani from Psychedelic Medicine Coalition. We got Jake Pelman from Mission Within Foundation. We're gonna talk about I bga I became policy on a recent, uh, set of meetings in Washington, DC and, uh, all sorts of other things I'm sure. Joe Moore: But thank you both for joining me. Melissa Lavasani: Thanks for having us. Jay Kopelman: Yeah, it's a pleasure. Thanks. Joe Moore: Yeah. Um, Melissa, I wanna have you, uh, jump in. First. Can you tell us a little bit about, uh, your work and what you do at PMC? Melissa Lavasani: Yeah, so Psychedelic Medicine Coalition is, um, the only DC based Washington DC based advocacy organization dedicated to the advancing the issue of psychedelics, um, and making sure the federal government has the education they need, um, and understands the issue inside out so that they can generate good policy around, around psychedelic medicines. Melissa Lavasani: [00:01:00] Uh, we. Host Hill events. We host other convenings. Our big event every year is the Federal Summit on psychedelic medicine. Um, that's going to be May 14th this year. Um, where we talk about kinda the pressing issues that need to be talked about, uh, with government officials in the room, um, so that we can incrementally move this forward. Melissa Lavasani: Um, our presence here in Washington DC is, is really critical for this issue's success because, um, when we're talking about psychedelic medicines, um, from the federal government pers perspective, you know, they are, they are the ones that are going to initiate the policies that create a healthcare system that can properly facilitate these medicines and make sure, um, patient safety is a priority. Melissa Lavasani: And there's guardrails on this. And, um, you know, there, it's, it's really important that we have. A home base for this issue in Washington DC just [00:02:00] because, uh, this is very complicated as a lot of your viewers probably understand, and, you know, this can get lost in the mix of all the other issues that, um, lawmakers in DC are focused on right now. Melissa Lavasani: And we need to keep that consistent presence here so that this continues to be a priority for members of Congress. Joe Moore: Mm. I love this. And Jay, can you tell us a bit about yourself and mission within Foundation? Jay Kopelman: Yeah, sure. Joe, thanks. Uh, I, I am the CEO of Mission within Foundation. Prior to this, most of my adult life was spent in the military as a Marine. Jay Kopelman: And I came to this. Role after having, uh, a psychedelic assisted therapy experience myself at the mission within down in Mexico, which is where pretty much we all go. Um, we are here to help [00:03:00] provide, uh, access for veterans and first responders to be able to attend psychedelic assisted therapy retreats to treat issues like mild TBI, post-traumatic stress disorder, uh, depression, sometimes addiction at, at a very low level. Jay Kopelman: Um, and, and so we've, we've been doing this for a little more than a year now and have provided 250 plus scholarships to veterans and first responders to be able to access. These retreats and these, these lifesaving medicines. Um, we're also partnered, uh, you may or may not know with Melissa at Psychedelic Medicine Coalition to help advance education and policy, specifically the innovative, uh, therapy Centers of Excellence Act [00:04:00] that Melissa has worked for a number of years on now to bring to both Houses of Congress. Joe Moore: Thank you for that. Um, so let's chat a little bit about what this event was that just, uh, went down, uh, what, what was it two weeks ago at this point? Melissa Lavasani: Yeah. Yeah. It's called For Veteran Society and it's all, um, there's a lot of dialogue on Capitol Hill about veterans healthcare and psychedelics, but where I've been frustrated is that, you know, it was just a lot of. Melissa Lavasani: Talk about what the problems are and not a lot of talk about like how we actually propel things forward. Um, so it, at that event, I thought it was really important and we had three members of Congress there, um, Morgan Latrell, who has been a champion from day one and his time in Congress, um, having gone through the experience himself, um, [00:05:00] at Mission within, um, and then the two chairs of the psychedelic caucus, uh, Lou Correa and Jack Bergman. Melissa Lavasani: And we really got down to the nitty gritty of like w like why this has taken so long and you know, what is actually happening right now? What are the possibilities and what the roadblocks are. And it was, I thought it was a great conversation. Um, we had an interesting kind of dynamic with Latres is like a very passionate about this issue in particular. Melissa Lavasani: Um, I think it was, I think it was really. A great event. And, you know, two days later, Jack Bergman introduced his new bill for the va. Um, so it was kind of like the precursor to that bill getting introduced. And we're just excited for more and more conversations about how the government can gently guide this issue to success. Joe Moore: Hmm. Yeah. [00:06:00] That's fantastic. Um, yeah, I was a little bummed I couldn't make it, but next time, I hope. But I've heard a lot of good things and, um, it's, it sounded like there was some really important messages in, in terms of like feedback from legislators. Yeah. Yeah. Could you speak to that? Melissa Lavasani: Yeah, I mean, I think when, uh, representative Latrell was speaking, he really impressed on us a couple things. Melissa Lavasani: Um, first is that, you know, they really kind of need the advocates to. Coordinate, collaborate and come up with like a, a strategic plan, you know, without public education. Um, talking to members of Congress about this issue is, is really difficult. You know, like PMC is just one organization. We're very little mission within, very little, um, you know, we're all like, kind of new in navigating, um, this not so new issue, but new to Washington DC [00:07:00] issue. Melissa Lavasani: Um, without that public education as a baseline, uh, it's, it's, you have to spend a lot of time educating members of Congress. You know, that's like one of our things is, you know, we have to, we don't wanna tell Congress what direction to go to. We wanna provide them the information so they understand it very intimately and know how to navigate through things. Melissa Lavasani: Um, and secondly. Um, he got pretty frank with us and said, you know, we've got one cha one chance at this issue. And it's like, that's, that's kind of been like my talking point since I started. PMC is like, you have a very limited window, um, when these kind of issues pop up and they're new and they're fresh and you have a lot of the veteran community coming out and talking about it. Melissa Lavasani: And there's a lot of energy there. But now is the time to really move forward, um, with some real legislation that can be impactful. Um, but, you know, we've gotta [00:08:00] be careful. We, we forget, I think sometimes those of us who are in the ecosystem forget that our level of knowledge about these medicines and a lot of us have firsthand experience, um, with these drugs and, and our own healing journeys is, um, we forget that there is a public out there that doesn't have the level of knowledge that we all have. Melissa Lavasani: And, um. We gotta make sure that we're sticking to the right elements of, of, of what needs to happen. We need to be sure that our talking points are on track and we're not getting sideways about anything and going down roads that we don't need to talk about. It's why, um, you know, PMC is very focused on, um, moving forward veteran legislation right now. Melissa Lavasani: Not because we're a veteran organization, but because we're, we see this long-term policy track here. Um, we know where we want to get [00:09:00] to, um. Um, and watching other healthcare issues kind of come up and then go through the VA healthcare system, I think it's a really unique opportunity, um, to utilize the VA as this closed system, the biggest healthcare system in the country to evaluate, uh, how psychedelics operate within systems like that. Melissa Lavasani: And, you know, before they get into, um, other healthcare systems. What do we need to fix? What do we need to pay attention to? What's something that we're paying too much attention to that doesn't necessarily need that much attention? So it's, um, it's a real opportunity to look at psychedelic medicines within a healthcare system and obviously continue to gather the data. Melissa Lavasani: Um, Bergman's Bill emerging, uh, expanding veteran access to emerging treatments. Um, not only mandates the research, it gives the VA authority for this, uh, for running trials and, and creating programs around psychedelic medicines. But also, [00:10:00] one of the great things about it, I think, is it provides an on-ramp for veterans that don't necessarily qualify for clinical trials. Melissa Lavasani: You know, I think that's one of the biggest criticisms of clinical trials is like you're cre you're creating a vacuum for people and people don't live in a vacuum. So we don't necessarily know what psychedelics are gonna look like in real life. Um, but with this expanding veteran access bill that Bergman introduced, it provides the VA an opportunity to provide this access under. Melissa Lavasani: Um, in a, in a safe container with medical supervision while collecting data, um, while ensuring that the veteran that is going through this process has the support systems that it needs. So, um, you know, I think that there's a really unique opportunity here, and like Latrell said, like, we've got one shot at this. Melissa Lavasani: We have people's attention in Congress. Um, now's the time to start acting, and let's be really considerate and thoughtful about what we're doing with it. Joe Moore: Thanks for that, Melissa and Jay, how, [00:11:00] anything to add there on kind of your takeaways from the this, uh, last visit in dc? Jay Kopelman: Yeah, I, I think that Melissa highlighted it really well and there, there were a couple other things that I, I think, you know, you could kind of tie it all together with some other issues that we face in this country, uh, and that. Jay Kopelman: Uh, representative Correa brought up as well, but one of the things I wanted to go back and say is that veterans have kind of led this movement already, right? So, so it's a, it's a good jumping off point, right? That it's something people from both sides of the aisle, from any community in America can get behind. Jay Kopelman: You know, if you think about it, uh, in World War ii, you know, we had a million people serving our population was like, not even 200 million, but now [00:12:00] we have a population of 330 million, and at any given time there might be a million people in uniform, including the Reserve and the National Guard. So it's, it, it's an easy thing to get behind this small part of the population that is willing to sign that contract. Jay Kopelman: Where you are saying, yeah, I'm going to defend my country, possibly at the risk of my l my own life. So that's the first thing. The other thing is that the VA being a closed health system, and they don't have shareholders to answer to, they can take some risks, they can be innovative and be forward thinking in the ways that some other healthcare systems can't. Jay Kopelman: And so they have a perfect opportunity to show that they truly care for their veterans, which don't, I'm not saying they don't, but this would be an [00:13:00] opportunity to show that carrot at a whole different level. Uh, it would allow them to innovate and be a leader in something as, uh, as our friend Jim Hancock will say, you know. Jay Kopelman: When he went to the Naval Academy, they had the world's best shipbuilding program. Why doesn't the VA have the world's best care program for things like TBI and PTSD, which affects, you know, 40 something percent of all veterans, right? So, so there's, there's an opportunity here for the VA to lead from the front. Jay Kopelman: Um, the, these medicines provide, you know, reasonably lasting care where it's kind of a one and done. Whereas with the current systems, the, you know, and, and [00:14:00] again, not to denigrate the VA in any way, they're doing the best job they can with the tools in their toolbox, right? But maybe it's time for a trip to Home Depot. Jay Kopelman: Let's get some new tools. And have some new ways of fixing what's broken, which is really the way of doing things. It's not, veterans aren't broken, we are who we are. Um, but it's a, it's a way to fix what isn't working. So I, I think that, you know, given there's tremendous veteran homelessness still, you know, addiction issues, all these things that do translate to the population at large are things that can be worked on in this one system, the va that can then be shown to have efficacy, have good data, have [00:15:00] good outcomes, and, and take it to the population at large. Joe Moore: Mm-hmm. Brilliant. Thanks for that. And so there was another thing I wanted to pivot to, which is some of the recent press. So we've, um, seen a little bit of press around some, um, in one instance, some bad behavior in Mexico that a FI put out Americans thrive again, put out. And then another case there was a, a recent fatality. Joe Moore: And I think, um, both are tragic. Like we shouldn't be having to deal with this at this point. Um, but there's a lot of things that got us here. Um, it's not necessarily the operator's fault entirely, um, or even at all, honestly, like some medical interventions just carry a lot of risk. Like think, think about like, uh, how risky bypass surgery was in the nineties, right? Joe Moore: Like people were dying a lot from medical interventions and um, you know, this is a major intervention, uh, ibogaine [00:16:00] and also a lot of promise. To help people quite a bit. Um, but as of right now, there's, there's risk. And part of that risk, in my opinion, comes from the inability of organizations to necessarily collaborate. Joe Moore: Like there's no kind of convening body, sitting in the middle, allowing, um, for, and facilitating really good data sharing and learnings. Um, and I don't, I don't necessarily see an organization stepping up and being the, um, the convener for that kind of work. I've heard rumors that something's gonna happen there, and I'm, I'm hopeful I'll always wanna share my opinion on that. Joe Moore: But yeah. I don't know. Jay, from your perspective, is there anything you want to kind of speak to about, uh, these two recent incidents that Americans for Iboga kind of publicized recently? Jay Kopelman: Yeah, so I, I'll echo your sentiment, of course, that these are tragic incidents. Um, and I, [00:17:00] I think that at least in the case of the death at Ambio, AMBIO has done a very good job of talking about it, right? Jay Kopelman: They've been very honest with the information that they have. And like you said, there are risks inherent to these medicines, and it's like anything else in medicine, there are going to be risks. You know, when I went through, uh, when I, when I went through chemo, you know, there were, there are risks. You know, you don't feel well, you get sick. Jay Kopelman: Um, and, and it. There are processes in place to counter that when it happens. And there are processes and, and procedures and safety protocols in place when caring for somebody going through an ibogaine [00:18:00] journey. Uh, when I did it, we had EKG echocardiogram. You're on a heart monitor the entire time they push magnesium via iv. Jay Kopelman: You have to provide a urinalysis sample to make sure that there is nothing in your system that is going to potentially harm you. During the ibogaine, they have, uh, a cardiologist who is monitoring the heart monitors throughout the ibogaine experience. So the, the safety protocols are there. I think it's, I think it's just a matter of. Jay Kopelman: Standardizing them across all, all providers, right? Like, that would be a good thing if people would talk to one another. Um, as, as in any system, right? You've gotta have [00:19:00] some collaboration. You've gotta have standardization, you know, so, you know, they're not called standard operating procedures for nothing. Jay Kopelman: That means that in a, you know, in a given environment, everybody does things the same way. It's true in Navy and Marine Corps, air Force, army Aviation, they have standard operating procedures for every single aircraft. So if you fly, let's say the F 35 now, right? Because it's flown by the Navy, the Marine Corps, and the Air Force. Jay Kopelman: The, the emergency procedures in that airplane are standardized across all three services, so you should have the same, or, you know, with within a couple of different words, the same procedures and processes [00:20:00] across all the providers, right? Like maybe in one document you're gonna change, happy to glad and small dog to puppy, but it's still pretty much the, the same thing. Jay Kopelman: And as a service that provides scholarships to people to go access these medicines and go to these retreats, you know, my criteria is that the, this provider has to be safe. Number one, safety's paramount. It's always gotta be very safe. It should, it has to be effective. And you know, once you have those two things in place, then I have a comfort level saying, okay, yeah, we'll work with this provider. Jay Kopelman: But until those standardized processes are in place, you'll probably see these one-off things. I mean, some providers have been doing this longer than others and have [00:21:00] really figured out, you know, they've, they've cracked the code and, you know, sharing that across the spectrum would be good. Um, but just when these things happen, having a clearing house, right, where everybody can come together and talk about it, you know, like once the facts are known because. Jay Kopelman: To my knowledge, we still don't know all the facts. Like as, you know, as horrible as this is, you still have to talk about like an, has an autopsy been performed? What was found in the patient's system? You know, there, there are things there that we don't know. So we need to, we need to know that before we can start saying, okay, well this is how we can fix that, because we just don't know. Jay Kopelman: And, you know, to their credit, you know, Amio has always been safe to, to the, to the best of my knowledge. You know, I, [00:22:00] I haven't been to Ambio myself, but people that I have worked with have been there. They have observed, they have seen the process. They believe it's safe, and I trust their opinion because they've seen it elsewhere as well. Jay Kopelman: So yeah, having, having that one place where we can all come together when this happens, it, it's almost like it should be mandatory. In the military when there's a training accident, we, you know, we would have to have what's called a safety standout. And you don't do that again for a little while until you figure out, okay, how are we going to mitigate that happening again? Jay Kopelman: Believe me, you can go overboard and we don't want to do that. Like, we don't wanna just stop all care, but maybe stop detox for a week and then come back to it. [00:23:00] Joe Moore: Yeah. A dream would be, let's get like the, I don't know, 10, 20 most popular, uh, or well-known operators together somewhere and just do like a three day debrief. Joe Moore: Hey, everybody, like, here's what we see. Let's work on this together. You know how normal medicine works. And this is, it's hard because this is not necessarily, um, something people feel safe about in America talking about 'cause it's illicit here. Um, I don't understand necessarily how the operations, uh, relate to each other in Mexico, but I think that's something to like the public should dig into. Joe Moore: Like, what, what is this? And I, I'll start digging into that. Um, I, I asked a question recently of somebody like, is there some sort of like back channel signal everybody's using and there's no clear Yes. You know? Um, I think it would be good. That's just a [00:24:00] start, you know, that's like, okay, we can actually kind of say hi and watch out for this to each other. Jay Kopelman: It's not like we don't all know one another, right? Joe Moore: Yes. Jay Kopelman: Like at least three operators we're represented. At the Aspen Ibogaine meeting. So like that could be, and I think there was a panel kind of loosely related to this during Aspen Ibogaine meeting, but Joe Moore: mm-hmm. Jay Kopelman: It, you know, have a breakout where the operators can go sit down and kind of compare notes. Joe Moore: Right. Yeah. Melissa, do you have any, uh, comments on this thread here? And I, I put you on mute if you didn't see that. Um, Melissa Lavasani: all right, I'm off mute. Um, yeah, I think that Jay's hits the nail on the head with the collaboration thing. Um, I think that it's just a [00:25:00] problem across the entire ecosystem, and I think that's just a product of us being relatively new and upcoming field. Melissa Lavasani: Um, uh, it's a product of, you know. Our fundraising community is really small, so organizations feel like they are competing for the same dollars, even though their, their goals are all the same, they have different functions. Um, I think with time, I mean, let's be honest, like if we don't start collaborating and, and the federal government's moving forward, the federal government's gonna coordinate for us. Melissa Lavasani: And not, that might not necessarily be a bad thing, but, you know, we understand this issue to a whole other level that the federal government doesn't, and they're not required to understand it deeply. They just need to know how to really move forward with it the proper way. Um, but I think that it. It's really essential [00:26:00] that we all have this come together moment here so we can avoid things. Melissa Lavasani: Uh, I mean, no one's gonna die from bad advocacy. So like I've, I have a bit of an easier job. Um, but it can a, a absolutely stall efforts, um, to move things forward in Washington DC when, um, one group is saying one thing, another group is saying another thing, like, we're not quite at a point yet where we can have multiple lines of conversation and multiple things moving forward. Melissa Lavasani: Um, you know, for PMC, it's like, just let's get the first thing across the finish line. And we think that is, um, veteran healthcare. And, um, I know there's plenty of other groups out there that, that want the same thing. So, you know, I always, the reason why I put on the Federal Summit last year was I kind of hit my breaking point with a lack of collaboration and I wanted to just bring everyone in the same room and say like, all right, here are the things that we need to talk about. Melissa Lavasani: And I think the goal for this year is, um. To bring people in the same room and say, we talked about [00:27:00] we scratched the surface last year and this is where we need to really put our efforts into. And this is where the opportunities are. Um, I think that is going to, that's going to show the federal government if we can organize ourselves, that they need to take this issue really seriously. Melissa Lavasani: Um, I don't think we've done a great job at that thus far, but I think there's still plenty of time for us to get it together. Um, and I'm hoping with these two, uh, VA bills that are in the house right now and Senate is, is putting together their version of these two bills, um, so that they can move in tandem with each other. Melissa Lavasani: I think that, you know, there's an opportunity here for. Us to show the federal government as an ecosystem, Hey, we, we are so much further ahead and you know, this is what we've organized and here's how we can help you, um, that would make them buy into this issue a bit more and potentially move things forward faster. Melissa Lavasani: Uh, at this point in time, it's, I think that, [00:28:00] you know, psychedelics aren't necessarily the taboo thing that they, they used to be, but there's certainly places that need attention. Um, there's certainly conversations that need to be had, and like I said, like PMC is just one organization that can do this. Um, we can certainly organize and drive forward collaboration, but I, like we alone, cannot cover all this ground and we need the subject matter experts to collaborate with us so we can, you know, once we get in the door, we wanna bring the experts in to talk to these officials about it. Melissa Lavasani: So I. I, I really want listeners to really think about us as a convener of sorts when it comes to federal policy. Um, and you know, I think when, like for example, in the early eighties, a lot of people have made comparisons to the issue of psychedelics to the issue of AIDS research and how you have in a subject matter that's like extremely taboo and a patient population that the government [00:29:00] quite honestly didn't really care about in the early eighties. Melissa Lavasani: But what they did as an ecosystem is really organized themselves, get very clear on what they wanted the federal government to do. And within a matter of a couple years, uh, AIDS research funding was a thing that was happening. And what that, what that did was that ripple effect turned that into basically finding new therapies for something that we thought was a death, death sentence before. Melissa Lavasani: So I think. We just need to look at things in the past that have been really successful, um, and, and try to take the lessons from all of these issues and, and move forward with psychedelics. Joe Moore: Love that. And yes, we always need to be figuring out efficient approaches and where it has been successful in the past is often, um, an opportunity to mimic and, and potentially improve on that. Melissa Lavasani: Yeah. Jay Kopelman: One, one thing I think it's important to add to this part of the conversation is that, [00:30:00] you know, Melissa pointed out there are a number of organizations that are essentially doing the same thing. Jay Kopelman: Um, you know, I like to think we do things a little bit differently at Mission within Foundation in that we don't target any one specific type of service member. We, we work with all veterans. We work with first responders, but. What that leads to is that there are, as far as I've seen, nothing but good intentioned people in this space. Jay Kopelman: You know, people who really care about their patient population, they care about healing, they are trying to do a good job, and more importantly, they're trying to do good. Right? It, it, I think they all see the benefit down the road that this has, [00:31:00] pardon me, not just for veterans, but for society as a whole. Jay Kopelman: And, and ultimately that's where I would like to see this go. You know, I, I would love to see the VA take this. Take up this mantle and, and run with it and provide great data, great outcomes. You know, we are doing some data collection ourselves at Mission within foundation, albeit anecdotal based on surveys given before and after retreats. Jay Kopelman: But we're also working with, uh, Greg Fonzo down at UT Austin on a brain study he's doing that will have 40 patients in it when it's all said and done. And I think we have two more guys to put through that. Uh, and then we'll hit the 40. So there, there's a lot of good here that's being done by some really, really good people who've been doing this for a long time [00:32:00] and want to want nothing more than to, to see this. Jay Kopelman: Come to, come full circle so that we can take care of many, many, many people. Um, you know, like I say, I, I wanna work myself out of a job here. I, I just, I would love to see this happen and then I, you know, I don't have to send guys to Mexico to do this. They can go to their local VA and get the care that they need. Jay Kopelman: Um, but one thing that I don't think we've touched on yet, or regarding that is that the VA isn't designed for that. So it's gonna be a pretty big lift to get the right types of providers into the va with the knowledge, right, with the institutional knowledge of how this should be done, what is safe, what is effective, um, and then it, it's not just providing these medicines to [00:33:00] people and sending them home. Jay Kopelman: You don't just do that, you've gotta have the right therapists on the backend who can provide the integration coaching to the folks who are receiving these medicines. And I'm not just talking, I bga, even with MDMA and psilocybin, you should have a proper period of integration. It helps you to understand how this is going to affect you, what it, what the experience really meant, you know, because it's very difficult sometimes to just interpret it on your own. Jay Kopelman: And so what the experience was and what it meant to you. And, and so it will take some time to spin all that up. But once it's, once it's in place, you know, the sky's the limit. I think. Joe Moore: Kinda curious Jay, about what's, what's going on with Ibogaine at the federal level. Is there anything at VA right now? [00:34:00] Jay Kopelman: At the va? No, not with ibogaine. And, you know, uh, we, we send people specifically for IBOGAINE and five MEO, right? And, and so that, that doesn't preclude my interest in seeing this legislation passed, right? Jay Kopelman: Because it, it will start with something like MDMA or psilocybin, but ultimately it could grow to iboga, right? It the think about the cost savings at, at the va, even with psilocybin, right? Where you could potentially treat somebody with a very inexpensive dose of psilocybin or, or iboga one time, and then you, you don't have to treat them again. Jay Kopelman: Now, if I were, uh, you know, a VA therapist who's not trained in psychedelic trauma therapy. I might be worried [00:35:00] about job security, but it's like with anything, right? Like ultimately it will open pathways for new people to get that training or the existing people to get that training and, and stay on and do that work. Jay Kopelman: Um, which only adds another arrow to their quiver as far as I'm concerned, because this is coming and we're gonna need the people. It's just like ai, right? Like ai, yeah. Some people are gonna lose some jobs initially, and that's unfortunate. But productivity ultimately across all industries will increase and new jobs will be created as a result of that. Jay Kopelman: I mean, I was watching Squawk Box one morning. They were talking about the AI revolution and how there's gonna be a need for 500,000 electricians to. Build these systems that are going to work with the AI [00:36:00] supercomputers and, and so, Joe Moore: mm-hmm. Jay Kopelman: Where, where an opportunity may be lost. I think several more can be gained going forward. Melissa Lavasani: And just to add on what Jay just said there, there's nothing specific going on with Ibogaine at, at the va, but I think this administration is, is taking a real look at addiction in particular. Uh, they just launched, uh, a new initiative, uh, that's really centered on addiction treatments called the Great American Recovery. Melissa Lavasani: And, um, they're dedicating a hundred million dollars towards treating addiction as like a chronic treatable disease and not necessarily a law enforcement issue. So, um, in that initiative there will be federal grant programs for prevention and treatment and recovery. And, um, while this isn't just for psychedelic medicines, uh, I think it's a really great opportunity for the discussion of psychedelics to get elevated to the White House. Melissa Lavasani: Um, [00:37:00] there's also, previous to this announcement last week from the White House, there's been a hundred million dollars that was dedicated at, um, at ARPA h, which is. The advanced research projects, uh, agency for healthcare, um, and that is kind of an agency that's really focused on forward looking, um, treatments and technologies, uh, for, um, a, a whole slew of. Melissa Lavasani: Of issues, but this a hundred million dollars is dedicated to mental health and addiction. So there's a lot of opportunity there as well. So we, while I think, you know, some people are talking about, oh, we need a executive order on Iboga, it's like, well, you know, the, the president is thinking, um, about, you know, what issues can land with his, uh, voting block. Melissa Lavasani: And I think it's, I don't think we necessarily need a specific executive order on Iboga to call this a success. It's like, let's look at what, [00:38:00] um, what's just been announced from the White House. They're, they're all in on. Thinking creatively and finding, uh, new solutions for this. And this is kind of, this aligns with, um, HHS secretaries, uh, Robert F. Melissa Lavasani: Kennedy Junior's goals when he took on this, this role of Health Secretary. Um, addiction has been a discussion that, you know, he has personal, um, a personal tie to from his own experience. And, um, I think when this administration started, there was so much like fervor around the, the dialogue of like, everyone's talking about psychedelics. Melissa Lavasani: It was Secretary Kennedy, it was, uh, secretary Collins at the va. It was FDA Commissioner Marty Macari. And I think that there's like a lot of undue frustration within folks 'cause um, you don't necessarily snap your fingers and change happens in Washington dc This is not the city for that. And it's intentionally designed to move slow so that we can avoid really big mistakes. Melissa Lavasani: Um. [00:39:00] I think we're a year into this administration and these two announcements are, are pretty huge considering, um, you know, the, we, there are known people within domestic policy council that don't, aren't necessarily supportive of psychedelic medicine. So there's a really amazing progress here, and frustrating as it might be to, um, just be waiting for this administration to make some major move. Melissa Lavasani: I think they are making major moves like for Washington, DC These, these are major moves and we just gotta figure out how we can, um, take these initiatives and apply them to the issue of psychedelic medicines. Joe Moore: Thanks, Melissa. Um, yeah, it is, it is interesting like the amount of fervor there was at the beginning. You know, we had, uh. Kind of one of my old lawyers, Matt Zorn, jumped in with the administration. Right. And, um, you know, it was, uh, really cool to [00:40:00] see and hopeful how much energy was going on. It's been a little quiet, kind of feels like a black box a little bit, but I, you know, there was, Melissa Lavasani: that's on me. Melissa Lavasani: Maybe I, we need to be more out in public about like, what's actually happening, because I feel like, like day in and day out, it's just been, you gotta just mm-hmm. Like have that constant beat with the government. Mm-hmm. And, um, it's, it's, it's not the photo ops on the hill, it's the conversations that you have. Melissa Lavasani: It's the dinner parties you go to, it's the fundraisers you attend, you know? Mm-hmm. That's why I, I kind of have to like toot my own horn with PCs. Like, we need to be present here at, at not only on the Hill, not only at the White House, but kind of in the ecosystem of Washington DC itself. There's, it's, there are like power players here. Melissa Lavasani: There are people that are connected that can get things done, like. I mean, the other last week we had a big snow storm. I walked over to my friend's house, um, to have like a little fire sesh with them and our kids, and his next door neighbor came over. He was a member of Congress. I talked about the VA bills, like [00:41:00] we're reaching out to his office now, um, to get them, um, up to speed and hopefully get their co-sponsorship for, uh, the two VA bills. Melissa Lavasani: So, I mean, it, the little conversations you have here are just as important as the big ones with the photo ops. So, um, it, it's, it's really like, you know, building up that momentum and, and finding that time where you can really strike and make something happen. Joe Moore: Mm-hmm. Yeah. Jay, anything to add there? Jay Kopelman: Yeah, I was just gonna say that, you know, I, I, I think the fervor is still there, right? Jay Kopelman: But real life happens. Melissa Lavasani: Yes, Jay Kopelman: yes. And gets in the way, right? So, Melissa Lavasani: yeah, Jay Kopelman: I, I can't imagine how many issues. Secretary Kennedy has every day much less the president. Like there's so many things that they are dealing with on a daily basis, right? It, we, we just have to work to be the squeaky wheel in, in the right way, right. Jay Kopelman: [00:42:00] With the, with the right information at the right time. Like just inundating one of these organizations with noise, it's then it be with Informa, it just becomes noise, right? It it, it doesn't help. So when we have things to say that are meaningful and impactful, we do, and Melissa does an amazing job of that. Jay Kopelman: But, you know, it, it takes time. You know, it's, you know, we're not, this is, this is like turning an aircraft carrier, not a ski boat. Melissa Lavasani: Yeah, Joe Moore: yeah, absolutely. Um, and. It's, it's understandably frustrating, I think for the public and the psychedelic public in particular because we see all this hope, you know, we continue to get frustrated at politics. It's nothing new, right? Um, and we, we wanna see more people get well immediately. [00:43:00] And I, I kind of, Jay from the veteran perspective, I do love the kind of loud voices like, you're making me go to Mexico for this. Joe Moore: I did that and you're making me leave the country for the thing that's gonna fix me. Like, no way. And barely a recognition that this is a valid treatment. You know, like, you know, that is complicated given how medicine is structured here domestically. But it's also, let's face the facts, like the drug war kind of prevented us from being able to do this research in the first place. Joe Moore: You know? Thanks Nixon. And like, how do we actually kind of correct course and say like, we need to spend appropriately on science here so we can heal our own people, including veterans and everybody really. It's a, it's a dire situation out there. Jay Kopelman: Yeah. It, it really is. Um, you know, we were talking briefly about addicts, right? Jay Kopelman: And you know, it's not sexy. People think of addicts as people who are weak-minded, [00:44:00] right? They don't have any self-control. Um, but, but look at, look at the opioid crisis, right? That Brian Hubbard was fighting against in Kentucky for all those years. That that was something that was given to the patient by a doctor that they then became dependent on, and a lot of people died from that. Jay Kopelman: And, and so you, you know, it's, I I don't think it's fair to just put all addicts in a box. Just like it's not fair to put all veterans in a box. Just like it's not fair for doctors, put all their patients in a box. We're individuals. We, we have individual needs. Our, our health is very individual. Like, I, I don't think I should be put in the same box as every other 66-year-old that my doctor sees. Jay Kopelman: It's not fair. [00:45:00] You know, if you, if you took my high school classmates and put us all in a photo, we're all gonna have different needs, right? Like, some look like they're 76, not 66. Some look like they're 56. Not like they're, we, we do things differently. We live our lives differently. And the same is true of addicts. Jay Kopelman: They come to addiction from different places. Not everybody decides they want to just try heroin at a party, and all of a sudden they're addicted. It happens in, in different ways, you know, and the whole fentanyl thing has been so daggum nefarious, right? You know, pushing fentanyl into marijuana. Jay Kopelman: Somebody's smoking a joint and all of a sudden they're addicted to fentanyl or they die. Melissa Lavasani: I think we're having a, Jay Kopelman: it's, it's just not fair to, to say everybody in this pot is the same, or everybody in this one is the same. We have [00:46:00] to look at it differently. Joe Moore: Yeah. I like to zoom one level out and kind of talk about, um, just how hurt we are as a country, as a world really, but as a country specifically, and how many people are out of work for so many. Joe Moore: Difficult reasons and away from their families for so many kind of tragic reasons. And if we can get people back to their families and back to work, a lot of these things start to self-correct, but we have to like have those interventions where we can heal folks and, and get them back. Um, yeah. And you know, everything from trauma, uh, in childhood, you know, adulthood, combat, whatever it is. Joe Moore: Like these things can put people on the sidelines. And Jay, to your point, like you get knee surgery and all of a sudden you're, you know, two years later you're on the hunt for Fentanyl daily. You know, that's tough. It's really tough. Carl Hart does a good job talking about this kind of addiction pipeline and [00:47:00] a few others do as well. Joe Moore: But it's just, you know, kind of putting it in a moral failure bucket. It's not great. I was chatting with somebody about, um, veterans, it's like you come back and you're like, what's gonna make me feel okay right now? And it's not always alcohol. Um, like this is the first thing that made me feel okay, because there's not great treatments and there's, there's a lot of improvements in this kind of like bringing people back from the field that needs to happen. Joe Moore: In my opinion. I, it seems to be shared by a lot of people, but yeah, there's, it's, it's, IGA is gonna be great. It's gonna be really important. I really can't wait for it to be at scale appropriately, but there's a lot of other things we need to fix too, um, so that we can just, you know, not have so many people we need to, you know, spend so much money healing. Joe Moore: Mm-hmm. Jay Kopelman: Yeah. You ahead with that. We don't need the president to sign an executive order to automatically legalize Ibogaine. Right. But it would be nice if he would reschedule it so that [00:48:00] then then researchers could do this research on a larger scale. You know, we could, we could now get some real data that would show the efficacy. Jay Kopelman: And it could be done in a safe environment, you know? And, and so that would be, do Joe Moore: you have any kind of figures, like, like, I've been talking about this for a while, Jay. Like, does it drop the cost a lot of doing research when we deschedule things? Jay Kopelman: I, I would imagine so, because it'll drop the cost of accessing the medicines that are being researched. Jay Kopelman: Right? You, you would have buy-in from more organizations. You know, you might even have a pharma company that comes into this, you know, look at j and j with the ketamine, right? They have, they have a nasal spray version of ketamine that's doing very well. I mean, it's probably their, their biggest revenue [00:49:00] provider for them right now. Jay Kopelman: And, and so. You know, you, it would certainly help and I think, I think it would lower costs of research to have something rescheduled rather than being schedule one. You know it, people are afraid to take chances when you're talking about Schedule one Melissa Lavasani: labs or they just don't have the money to research things that are on Schedule one. Melissa Lavasani: 'cause there's so much in an incredible amount of red tape that you have to go through and, and your facility has to be a certain way and how you contain those, uh, medicines. Oh, researching has to be in a specific container and it's just very cumbersome to research schedule one drugs. So absolutely the cost would go down. Melissa Lavasani: Um, but Joe Moore: yeah, absolutely. Less safes. Melissa Lavasani: Yeah. Joe Moore: Yes. Less uh, Melissa Lavasani: right. Joe Moore: Locked. Yeah. Um, it'll be really interesting when that happens. I'm gonna hold out faith. That we can see some [00:50:00] movement here. Um, because yeah, like why make healing more expensive than it needs to be? I think like that's potentially a protectionist move. Joe Moore: Like, I'm not, I'm not here yet, but, um, look at AbbVie's, uh, acquisition of the Gilgamesh ip. Mm-hmm. Like that's a really interesting move. I think it was $1.2 billion. Mm-hmm. So they're gonna wanna protect that investment. Um, and it's likely going to be an approved medication. Like, I don't, I don't see a world in which it's not an approved medication. Joe Moore: Um, you know, I don't know a timeline, I would say Jay Kopelman: yeah. Joe Moore: Less than six years, just given how much cash they've got. But who knows, like, I haven't followed it too closely. So, and that's an I bga derivative to be clear, everybody, um mm-hmm. If you're not, um, in, in the loop on that, which is hopeful, you know? Joe Moore: Mm-hmm. But I don't know what the efficacy is gonna be with that compared to Ibogaine and then we have to talk about the kind of proprietary molecule stuff. Um, there's like a whole bunch of things that are gonna go on here, and this is one of the reasons why I'm excited about. Federal involvement [00:51:00] because we might actually be able to have some sort of centralized manufacturer, um, or at least the VA could license three or four generic manufacturers per for instance, and that way prices aren't gonna be, you know, eight grand a dose or whatever. Joe Moore: You know, it's, Jay Kopelman: well, I think it's a very exciting time in the space. You know, I, I think that there's the opportunity for innovation. There is the opportunity for collaboration. There's the opportunity for, you know, long-term healing at a very low cost. You know, that we, we have the highest healthcare cost per capita in the world right here in the us. Jay Kopelman: And, and yet we are not the number one health system in the world. So to me, that doesn't add up. So we need to figure out a way to start. Bringing costs down for a lot of people and [00:52:00] at the same time increasing, increasing outcomes. Joe Moore: Absolutely. Yeah. There's a lot of possible outcome improvements here and, and you know, everything from relapse rates, like we hear often about people leaving a clinic and they go and overdose when they get home. Tragically, too common. I think there's everything from, you know, I'm Jay, I'm involved in an organization called the Psychedelics and Pain Association. Joe Moore: We look at chronic pain very seriously, and IGA is something we are really interested in. And if. We could have better, you know, research, there better outcome measures there. Um, you know, perhaps we can have less people on opioids to begin with from chronic pain conditions. Um, Jay Kopelman: yeah, I, I might be due for another Ibogaine journey then, because I deal with chronic pain from Jiujitsu, but, Joe Moore: oh gosh, let's Jay Kopelman: talk Joe Moore: later. Jay Kopelman: That's self inflicted. Some people would say take a month off, but Melissa Lavasani: yeah, Jay Kopelman: I'm [00:53:00] not, I'm not that smart. Joe Moore: Yeah. Um, but you know, this, uh, yeah, this whole thing is gonna be really interesting to see how it plays out. I'm endlessly hopeful pull because I'm still here. Right. I, I've been at this for almost 10 years now, very publicly, and I think we are seeing a lot of movement. Joe Moore: It's not always what we actually wanna see, but it is movement nonetheless. You know, how many people are writing on this now than there were before? Right. You know, we, we have people in New York Times writing somewhat regularly about psychedelics and. Even international media is covering it. What do we have legalization in Australia somewhat recently for psilocybin and MDMA, Czech Republic. Joe Moore: I think Germany made some moves recently. Mm-hmm. Um, really interesting to see how this is gonna just keep shifting. Um Jay Kopelman: mm-hmm. Joe Moore: And I think there's no way that we're not gonna have prescription psychedelics in three years in the United States. It pro probably more like a [00:54:00] year and a half. I don't know. Do you, are you all taking odds? Melissa Lavasani: Yeah. I mean, I think Jay Kopelman: I, I gotta check Cal sheet, see what they're saying. Melissa Lavasani: I think it's safe to say, I mean, this could even come potentially the end of this year, I think, but definitely by the end of 2027, there's gonna be at least one psychedelic that's FDA approved. Joe Moore: Yeah. Yeah. Melissa Lavasani: If you're not counting Ketamine. Joe Moore: Right. Jay Kopelman: I, I mean, I mean it mm-hmm. It, it doesn't make sense that it. Shouldn't be or wouldn't be. Right. The, we've seen the benefits. Mm-hmm. We know what they are. It's at a very low cost, but you have to keep in mind that these things, they need to be done with the right set setting and container. Right. And, and gotta be able to provide that environment. Jay Kopelman: So, but I would, I would love, like I said, I'd love to work myself out of a job here and see this happen, not just for our veterans, [00:55:00] but for everybody. Joe Moore: Mm-hmm. Um, so Melissa, is there a way people can get involved or follow PMC or how can they support your work at PMC? Melissa Lavasani: Yeah, I mean, follow us in social media. Melissa Lavasani: Um, our two biggest platforms are LinkedIn and Instagram. Um, I'm bringing my newsletter back because I'm realizing, um, you know, there is a big gap in, in kind of like the knowledge of Washington DC just in general. What's happening here, and I think, you know, part of PC's value is that we're, we are plugged into conversations that are being had, um, here in the city. Melissa Lavasani: And, you know, we do get a little insight. Um, and I think that that would really quiet a lot of, you know, the, a lot of noise that, um, exists in the, our ecosystem. If, if people just had some clarity on like, what's actually happening or happening here and what are the opportunities and, [00:56:00] um, where do we need more reinforcement? Melissa Lavasani: Um, and, and also, you know, as we're putting together public education campaign, you know. My, like, if I could get everything I wanted like that, that campaign would be this like multi-stakeholder collaborative effort, right? Where we're covering all the ground that we need to cover. We're talking to the patient groups, we're talking to traditional mental health organizations, we're talking to the medical community, we're talking to the general population. Melissa Lavasani: I think that's like another area that we, we just seem to be, um, lacking some effort in. And, you know, ultimately the veteran story's always super compelling. It pulls on your heartstrings. These are our heroes, um, of our country. Like that, that is, that is meaningful. But a lot of the veteran population is small and we need the, like a, the just.[00:57:00] Melissa Lavasani: Basic American living in middle America, um, understanding what psychedelics are so that in, in, in presenting to them the stories that they can relate to, um, because that's how you activate the public and you activate the public and you get them to see what's happening in these clinical trials, what the data's been saying, what the opportunities are with psychedelics, and then they start calling their members of Congress and saying, Hey, there is this. Melissa Lavasani: Bill sitting in Congress and why haven't you signed onto it? And that political pressure, uh, when used the right way can be really powerful. So, um, I think, you know, now we're at this really amazing moment where we have a good amount of congressional offices that are familiar enough with psychedelics that they're willing to move on it. Melissa Lavasani: Um, there's another larger group, uh, that is familiar with psychedelics and will assist and co-sponsor legislation, but there's still so many offices that we haven't been able to get to just 'cause like we don't have all the time in the world and all the manpower in the world to [00:58:00] do it. But, you know, that is one avenue is like the advocates can speak to the, the lawmakers, the experts speak to the lawmakers, and we not, we want the public engaged in this, you know, ultimately, like that's. Melissa Lavasani: Like the best form of harm reduction is having an informed public. So we are not, they're not seeing these media headlines of like, oh, this miracle cure that, um, saved my family. It's like, yes, that can happen psychedelics. I mean, person speaking personally, psychedelics did save my family. But what you miss out of that story is the incredible amount of work I put into myself and put into my mental health to this day to maintain, um, like myself, my, my own agency and like be the parent that I wanna be and be the spouse that I wanna be. Melissa Lavasani: So, um, we, we need to continue to share these stories and we need to continue to collaborate to get this message out because we're all, we're all in the same boat right now. We all want the same things. We want patients to have safe and [00:59:00] affordable access to psychedelic assisted care. Um, and, uh. We're just in the beginning here, so, um, sign up for our newsletter and we can sign up on our website and then follow us on social media. Melissa Lavasani: And, um, I anticipate more and more events, um, happening with PMC and hopefully we can scale up some of these events to be much more public facing, um, as this issue grows. So, um, I'm really excited about the future and I'm, I've been enjoying this partnership with Mission Within. Jay is such a professional and, and it really shows up when he needs to show up and, um, I look forward to more of that in the future. Joe Moore: Fantastic. And Jay, how can people follow along and support mission within Foundation? Jay Kopelman: Yeah, again, social media is gonna be a good way to do that. So we, we are also pretty heavily engaged on LinkedIn and on Instagram. Um, I do [01:00:00] share, uh, a bit of my own stuff as well. On social media. So we have social media pages for Mission within Foundation, and we have a LinkedIn page for mission within foundation. Jay Kopelman: I have my own profiles on both of those as well where people can follow along. Um, one of the other things you know that would probably help get more attention for this is if the general public was more aware of the numbers of professional athletes who are also now pursuing. I began specifically to help treat their traumatic brain injuries and the chronic traumatic encephalopathy that they've, uh, suffered as a result of their time in professional sports or even college sports. Jay Kopelman: And, you know. I people worship these athletes, and I [01:01:00] think that if more of them, like Robert Gall, were more outspoken about these treatments and the healing properties that they've provided them, that it would get even more attention. Um, I think though what Melissa said, you know, I don't wanna parrot anything she just said because she said it perfectly Right. Jay Kopelman: And I'd just be speaking to hear myself talk. Um, but being collaborative the way that we are with PMC and with Melissa is I think, the way to move the needle on this overall. And like she said, if she could get more groups involved in, in these discussions, it would, it would do wonders for us. Joe Moore: Well, thank you both so much for your hard work out there. I always appreciate it when people are showing up and doing this important, [01:02:00] sometimes boring and tedious, but nevertheless sometimes, sometimes exciting work. And um, so yeah, just thank you both and thank you both for showing up here to psychedelics today to join us and I hope we can continue to support you all in the future. Jay Kopelman: Thank you, Joe. Thank you, Joe. It's a pleasure being with you today and with Melissa, of course, always Melissa Lavasani: appreciate the time and space. Joe Moore: Thanks.